FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Thase

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Michael E Thase; Madhukar H Trivedi; Michael Bauer; Catherine Datto; Urban Gustafsson; Julie C Locklear; Stuart Montgomery; George I Papakostas; Henrik Svedsäter; Hans Eriksson
Quetiapine XR monotherapy in major depressive disorder: a pooled analysis to assess the influence of baseline severity on efficacy.
Robin B Jarrett; Julie L Kangas; Abu Minhajuddin; Judith A Callan; Edward S Friedman; Michael E Thase
Acute phase cognitive therapy for recurrent major depressive disorder: who drops out and how much do patient skills influence response?
Michael E Thase
Antidepressants and rapid-cycling bipolar II disorder: dogma, definitions and deconstructing discrepant data.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Thase (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michael E Thase; Madhukar H Trivedi; Michael Bauer; Catherine Datto; Urban Gustafsson; Julie C Locklear; Stuart Montgomery; George I Papakostas; Henrik Svedsäter; Hans Eriksson
Quetiapine XR monotherapy in major depressive disorder: a pooled analysis to assess the influence of baseline severity on efficacy.
International clinical psychopharmacology 2013;28(3):113-20.
2013: Robin B Jarrett; Julie L Kangas; Abu Minhajuddin; Judith A Callan; Edward S Friedman; Michael E Thase
Acute phase cognitive therapy for recurrent major depressive disorder: who drops out and how much do patient skills influence response?
Behaviour research and therapy 2013;51(4-5):221-30.
2013: Michael E Thase
Antidepressants and rapid-cycling bipolar II disorder: dogma, definitions and deconstructing discrepant data.
The British journal of psychiatry : the journal of mental science 2013;202(4):251-2.
2013: Yonghua Jing; Iftekhar Kalsekar; Robert A Forbes; Zhenchao Guo; Tony Hebden; Michael E Thase
Dosing patterns of aripiprazole and quetiapine for adjunctive treatment of major depressive disorder (2006-2010).
International clinical psychopharmacology 2013;28(2):87-90.
2013: Rakesh Jain; Atul R Mahableshwarkar; Yinzhong Chen; Paula L Jacobsen; Michael E Thase
A randomized, double-blind, placebo-controlled 6-wk trial of the efficacy and tolerability of 5 mg vortioxetine in adults with major depressive disorder.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2013;16(2):313-21.
2013: Joseph F Goldberg; Michael E Thase
Monoamine oxidase inhibitors revisited: what you should know.
The Journal of clinical psychiatry 2013;74(2):189-91.
2013: Susan G Kornstein; James Luther; A John Rush; Michael E Thase; Marisa Toups; Diane Warden; Stephen R Wisniewski; Maurizio Fava; Madhukar H Trivedi
Do menopausal status and use of hormone therapy affect antidepressant treatment response? Findings from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study.
Journal of women's health (2002) 2013;22(2):121-31.
2013: Anna R Brandon; Abu Minhajuddin; Michael E Thase; Robin B Jarrett
Impact of reproductive status and age on response of depressed women to cognitive therapy.
Journal of women's health (2002) 2013;22(1):58-66.
2013: Andrew A Nierenberg; Michael J Ostacher; Michael Pencina; Noreen Reilly-Harrington; Joanne B Severe; Louisa G Sylvia; Michael E Thase; Edward S Friedman; Dan V Iosifescu; Terence Ketter; Andrew C Leon; Charles L Bowden; Joseph R Calabrese
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium.
The American journal of psychiatry 2013;170(1):102-10.
2013: Stewart A. Shankman; Michael E Thase; Bruce A Arnow; Miranda L Campbell; Martin B Keller; Daniel N Klein; Andrew C Leon; Rachel Manber; John C Markowitz; Barbara O Rothbaum; James H Kocsis
Dysfunctional attitudes as a moderator of pharmacotherapy and psychotherapy for chronic depression.
Journal of psychiatric research 2013;47(1):113-21.
2012: Amy Farabaugh; Maurizio Fava; Ed Friedman; Aya Inamori; Maren Nyer; Michael W Otto; Roy Perlis; Jonathan Alpert; Lee Baer; Balasubramani G.K.; Stella Bitran; Madhukar Trivedi; Stephen R Wisniewski; Michael E Thase
Cognitive therapy for anxious depression in STAR(*) D: what have we learned?
Journal of affective disorders 2012;142(1-3):213-8.
2012: Boadie W Dunlop; Rana Fayyad; Christine J Guico-Pabia; Jeff Musgnung; Michael E Thase; Chuan-Chuan Wun; Philip T Ninan
A meta-analysis of factors impacting detection of antidepressant efficacy in clinical trials: the importance of academic sites.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2012;37(13):2830-6.
2012: Olivier Berton; Chang-Gyu Hahn; Michael E Thase
Are we getting closer to valid translational models for major depression?
Science (New York, N.Y.) 2012;338(6103):75-9.
2012: Dana Steidtmann; Michael E Thase; Bruce A Arnow; Daniel N Klein; Rachel Manber; John C Markowitz; Barbara O Rothbaum; James H Kocsis
Patient treatment preference as a predictor of response and attrition in treatment for chronic depression.
Depression and anxiety 2012;29(10):896-905.
2012: Greg J Siegle; Michael E Thase; Wesley K Thompson; Susan R Berman; Amanda Collier; Joshua Feldmiller; Edward S Friedman
Toward clinically useful neuroimaging in depression treatment: prognostic utility of subgenual cingulate activity for determining depression outcome in cognitive therapy across studies, scanners, and patient characteristics.
Archives of general psychiatry 2012;69(9):913-24.
2012: Michael E Thase
MAOIs and depression treatment guidelines.
The Journal of clinical psychiatry 2012;73(7):e24.
2012: Neven Henigsberg; Paula Jacobsen; Atul R Mahableshwarkar; Yinzhong Chen; Michael E Thase
A randomized, double-blind, placebo-controlled 8-week trial of the efficacy and tolerability of multiple doses of Lu AA21004 in adults with major depressive disorder.
The Journal of clinical psychiatry 2012;73(7):953-9.
2012: Michael E Thase; Mattias Udd; Koen Demyttenaere; Willie R Earley; Urban Gustafsson; Hans Åke Eriksson
Extended release quetiapine fumarate in major depressive disorder: analysis in patients with anxious depression.
Depression and anxiety 2012;29(7):574-86.
2012: Michael E Thase
Social skills training for depression and comparative efficacy research: a 30-year retrospective.
Behavior modification 2012;36(4):545-57.
2012: Michael E Thase
Applying antidepressant study results to clinical practice.
The Journal of clinical psychiatry 2012;73(6):e21.
2012: Michael E Thase; Charles L Bowden; James M Eudicone; Ronald Marcus; Robert D McQuade; Michael Nashat; Berit X Carlson
Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms.
International journal of psychiatry in clinical practice 2012;16(2):121-31.
2012: Chi-Un Pae; Kimberly Blanchard Portland; Michael E Thase; J Alexander Bodkin; Ashwin A Patkar
Safety of selegiline transdermal system in clinical practice: analysis of adverse events from postmarketing exposures.
The Journal of clinical psychiatry 2012;73(5):661-8.
2012: James Craig Nelson; Linda M Rollin; Michael E Thase; Elizabeth E Bellocchio; Robert M Berman; James M Eudicone; Ronald N Marcus; Robert D McQuade; Ross A Baker
Efficacy of adjunctive aripiprazole in patients with major depressive disorder who showed minimal response to initial antidepressant therapy.
International clinical psychopharmacology 2012;27(3):125-33.
2012: Robin B Jarrett; Cindy L Kidner; Abu Minhajuddin; Zindel V Segal; Patricia D Borman; Lauren Dunlap; Edward S Friedman; Michael E Thase
Cognitive reactivity, dysfunctional attitudes, and depressive relapse and recurrence in cognitive therapy responders.
Behaviour research and therapy 2012;50(5):280-6.
2012: Fritz Renner; Marna S Barrett; Lee Anna Clark; Robin B Jarrett; Jeffrey R Vittengl; Michael E Thase
Interpersonal problems as predictors of therapeutic alliance and symptom improvement in cognitive therapy for depression.
Journal of affective disorders 2012;138(3):458-67.
2012: Michael E Thase
Bipolar disorder maintenance treatment: monitoring effectiveness and safety.
The Journal of clinical psychiatry 2012;73(4):e15.
2012: Wendy M Troxel; Ellen Frank; David J Kupfer; Jean M Miewald; Charles F Reynolds; Michael E Thase; Daniel J Buysse
Insomnia and objectively measured sleep disturbances predict treatment outcome in depressed patients treated with psychotherapy or psychotherapy-pharmacotherapy combinations.
The Journal of clinical psychiatry 2012;73(4):478-85.
2012: Kevin Ryan Connolly; Michael E Thase
Emerging drugs for major depressive disorder.
Expert opinion on emerging drugs 2012;17(1):105-26.
2012: Charles L Bowden; Joseph Calabrese; Jodi Gonzalez; Terence A Ketter; Andrew A Nierenberg; M M Ostacher; R H Perlis; N A Reilly-Harrington; Vivek Singh; Michael E Thase; G S Sachs
Aims and results of the NIMH systematic treatment enhancement program for bipolar disorder (STEP-BD).
CNS neuroscience & therapeutics 2012;18(3):243-9.
2012: Michael E Thase
Strategies for increasing treatment adherence in bipolar disorder.
The Journal of clinical psychiatry 2012;73(2):e08.
2012: Louisa G Sylvia; Michael E Thase; Michael J Ostacher; Noreen A Reilly-Harrington; Joanne Severe; Charles L Bowden; Joseph R Calabrese; Edward S Friedman; Dan V Iosifescu; Christine I Kansky; Terence A Ketter; Michelle Keyes; Andrew C Leon; Andrew A Nierenberg
Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder.
Clinical trials (London, England) 2012;9(1):94-101.
2012: Lawrence J Cohen; Larry Culpepper; David A Flockhart; Robert M A Hirschfeld; David A Sclar; Michael E Thase; Chad M VanDenBerg
Discussion: a fresh look at monoamine oxidase inhibitors for depression.
The Journal of clinical psychiatry 2012;73 Suppl 1():42-5.
2012: Michael E Thase
The role of monoamine oxidase inhibitors in depression treatment guidelines.
The Journal of clinical psychiatry 2012;73 Suppl 1():10-6.
2012: Donovan Maust; Susan Rushing; Mario Cristancho; Laurie Gray; Chris Tjoa; Michael E Thase
Psychiatric rating scales.
Handbook of clinical neurology 2012;106():227-37.
2012: Jasper A J Smits; Michael E Thase; Abu Minhajuddin; Robin B Jarrett
Outcomes of acute phase cognitive therapy in outpatients with anxious versus nonanxious depression.
Psychotherapy and psychosomatics 2012;81(3):153-60.
2012: Michael E Thase
Using adjunctive treatments when first-line antidepressants fail.
The Journal of clinical psychiatry 2012;73(1):e01.
2012: Tina Marie Myers Oakes; Apurva Prakash; Michael E Thase; Jonna Ahl; Lauren B Marangell; Adam L Myers; Susan G Kornstein
Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol.
Human psychopharmacology 2012;27(1):47-56.
2012: Carol R Reed; Maria C Athanasiou; Susan Gallipoli; Daniel K Kajdasz; Heidi Whalen; Michael E Thase
The efficacy profile of vilazodone, a novel antidepressant for the treatment of major depressive disorder.
Current medical research and opinion 2012;28(1):27-39.
2011: Michael E Thase; Klaus G Larsen; Sidney H Kennedy
Assessing the 'true' effect of active antidepressant therapy v. placebo in major depressive disorder: use of a mixture model.
The British journal of psychiatry : the journal of mental science 2011;199(6):501-7.
2011: Michael E Thase
The small specific effects of antidepressants in clinical trials: what do they mean to psychiatrists?
Current psychiatry reports 2011;13(6):476-82.
2011: Michael E Thase
Combined antidepressant strategies are not more effective than vigorous escitalopram monotherapy: results of the CO-MED study.
Current psychiatry reports 2011;13(6):434-6.
2011: June Gruber; Allison G Harvey; Ellen Frank; David Kupfer; David J Miklowitz; Gary S Sachs; Michael E Thase; Terence A Ketter
Sleep matters: sleep functioning and course of illness in bipolar disorder.
Journal of affective disorders 2011;134(1-3):416-20.
2011: David J Carpenter; John T Davies; Regan Fong; John E Kraus; Christine Moore; Michael E Thase
Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials.
The Journal of clinical psychiatry 2011;72(11):1503-14.
2011: Ellen B Dennehy; Lauren B Marangell; Michael H Allen; Cheryl Chessick; Stephen R Wisniewski; Michael E Thase
Suicide and suicide attempts in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Journal of affective disorders 2011;133(3):423-7.
2011: Pilar Cristancho; Gordon H Baltuch; Mario A Cristancho; Michael E Thase; John P O'Reardon
Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year.
The Journal of clinical psychiatry 2011;72(10):1376-82.
2011: Yonghua Jing; Iftekhar Kalsekar; Erin Bagalman; Ginger S Carls; Suellen M Curkendall; Robert A Forbes; Tony Hebden; Michael E Thase
Intent-to-treat analysis of health care expenditures of patients treated with atypical antipsychotics as adjunctive therapy in depression.
Clinical therapeutics 2011;33(9):1246-57.
2011: Robin B Jarrett; Lee Anna Clark; Jeffrey R Vittengl; Michael E Thase
Skills of Cognitive Therapy (SoCT): a new measure of patients' comprehension and use.
Psychological assessment 2011;23(3):578-86.
2011: Michael E Thase
Antidepressant combinations: widely used, but far from empirically validated.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2011;56(6):317-23.
2011: Michael E Thase
Treatment-resistant depression: prevalence, risk factors, and treatment strategies.
The Journal of clinical psychiatry 2011;72(5):e18.
2011: Greg Siegle; Stuart R Steinhauer; Edward S Friedman; Wesley S Thompson; Michael E Thase
Remission prognosis for cognitive therapy for recurrent depression using the pupil: utility and neural correlates.
Biological psychiatry 2011;69(8):726-33.
2011: Claudio N Soares; Michael E Thase; Anita Clayton; Christine J Guico-Pabia; Kristen Focht; Qin Jiang; Susan G Kornstein; Phillip T Ninan; Cecelia P Kane
Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.
CNS drugs 2011;25(3):227-38.
2011: Niklaus Stulz; Michael E Thase; Robert Gallop; Paul Crits-Christoph
Psychosocial treatments for cocaine dependence: the role of depressive symptoms.
Drug and alcohol dependence 2011;114(1):41-8.
2011: Holly A Swartz; Michael E Thase
Pharmacotherapy for the treatment of acute bipolar II depression: current evidence.
The Journal of clinical psychiatry 2011;72(3):356-66.
2011: Michael E Thase; Alan Gelenberg; Susan G Kornstein; James H Kocsis; Madhukar H Trivedi; Philip Ninan; Thomas Li; Ron Pedersen; Martin Keller
Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study.
Journal of psychiatric research 2011;45(3):412-20.
2011: Scott H Kollins; Sharon Youcha; Robert Lasser; Michael E Thase
Lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder in adults with a history of depression or history of substance use disorder.
Innovations in clinical neuroscience 2011;8(2):28-32.
2011: Michael E Thase
The role of neurobiologic processes in symptoms of depression.
The Journal of clinical psychiatry 2011;72(2):e08.
2011: Deborah R Kim; Neill Epperson; Emmanuelle Paré; Juan M Gonzalez; Samuel Parry; Michael E Thase; Pilar Cristancho; Mary D Sammel; John P O'Reardon
An open label pilot study of transcranial magnetic stimulation for pregnant women with major depressive disorder.
Journal of women's health (2002) 2011;20(2):255-61.
2011: John O Brooks; Joseph F Goldberg; Terence A Ketter; David J Miklowitz; Joseph Calabrese; Charles L Bowden; Michael E Thase
Safety and tolerability associated with second-generation antipsychotic polytherapy in bipolar disorder: findings from the Systematic Treatment Enhancement Program for Bipolar Disorder.
The Journal of clinical psychiatry 2011;72(2):240-7.
2011: Kevin R Connolly; Michael E Thase
The clinical management of bipolar disorder: a review of evidence-based guidelines.
The primary care companion to CNS disorders 2011;13(4):.
2011: Michael E Thase; Jeff Musgnung; Philip T Ninan; Madhukar H Trivedi
Remission with venlafaxine extended release or selective serotonin reuptake inhibitors in depressed patients: a randomized, open-label study.
The primary care companion to CNS disorders 2011;13(1):.
2011: Robert M Berman; William Carson; James A Hazel; Sabrina Vogel Marler; Robert D McQuade; Michael E Thase; Madhukar H Trivedi; Ross A Baker; Ronald N Marcus
Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder.
Neuropsychiatric disease and treatment 2011;7():303-12.
2011: K Ryan Connolly; Michael E Thase
If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies.
Drugs 2011;71(1):43-64.
2011: Andrew J Gerber; James H Kocsis; Barbara L Milrod; Steven P Roose; Jacques P Barber; Michael E Thase; Patrick Perkins; Andrew C Leon
A quality-based review of randomized controlled trials of psychodynamic psychotherapy.
The American journal of psychiatry 2011;168(1):19-28.
2010: Roy H Perlis; Michael J Ostacher; Joseph F Goldberg; David J Miklowitz; Edward Friedman; Joseph Calabrese; Michael E Thase; Gary S Sachs
Transition to mania during treatment of bipolar depression.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010;35(13):2545-52.
2010: Mario A Cristancho; Michael E Thase
The role of quetiapine extended release in the treatment of bipolar depression.
Advances in therapy 2010;27(11):774-84.
2010: Madhukar H Trivedi; David L Dunner; Susan G Kornstein; Michael E Thase; John M Zajecka; Anthony J Rothschild; Edward S Friedman; Richard C Shelton; Martin B Keller; James H Kocsis; Alan J Gelenberg
Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release.
Journal of affective disorders 2010;126(3):420-9.
2010: Michael E Thase
The role of neurobiologic processes in treating depression.
The Journal of clinical psychiatry 2010;71(10):e28.
2010: Michael E Thase
No evidence for switching antidepressants in treatment-resistant depressed patients.
Evidence-based medicine 2010;15(4):120-1.
2010: Arif Khan; Amritha Bhat; Russell Kolts; Michael E Thase; Walter Brown
Why has the antidepressant-placebo difference in antidepressant clinical trials diminished over the past three decades?
CNS neuroscience & therapeutics 2010;16(4):217-26.
2010: Susan G Kornstein; Elizabeth A Young; Annie T Harvey; Stephen R Wisniewski; Jennifer L Barkin; Michael E Thase; Madhukar H Trivedi; Andrew A Nierenberg; A John Rush
The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in women.
Menopause (New York, N.Y.) 2010;17(4):828-39.
2010: Claudio N Soares; Michael E Thase; Anita Clayton; Christine J Guico-Pabia; Kristen Focht; Qin Jiang; Susan G Kornstein; Phil Ninan; Cecelia P Kane; Lee S Cohen
Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder.
Menopause (New York, N.Y.) 2010;17(4):700-11.
2010: Michael E Thase; Andrew A Nierenberg; Peter Vrijland; Helga J J van Oers; Albert-Jan Schutte; John H Simmons
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
International clinical psychopharmacology 2010;25(4):189-98.
2010: Robin B Jarrett; Michael E Thase
Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.
Contemporary clinical trials 2010;31(4):355-77.
2010: Niklaus Stulz; Michael E Thase; Daniel N Klein; Rachel Manber; Paul Crits-Christoph
Differential effects of treatments for chronic depression: a latent growth model reanalysis.
Journal of consulting and clinical psychology 2010;78(3):409-19.
2010: James H Kocsis; Andrew J Gerber; Barbara Milrod; Steven P Roose; Jacques Barber; Michael E Thase; Patrick Perkins; Andrew C Leon
A new scale for assessing the quality of randomized clinical trials of psychotherapy.
Comprehensive psychiatry 2010;51(3):319-24.
2010: Roy H Perlis; Michael J Ostacher; David J Miklowitz; Aleena Hay; Andrew A Nierenberg; Michael E Thase; Gary S Sachs
Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study.
The Journal of clinical psychiatry 2010;71(3):296-303.
2010: W H Denton; Thomas J Carmody; john rush; Michael E Thase; Madhukar H Trivedi; Bruce A Arnow; Daniel N Klein; Martin B Keller
Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression.
Psychological medicine 2010;40(3):415-24.
2010: Roy H Perlis; Michael J Ostacher; David J Miklowitz; Jordan W Smoller; Ellen B Dennehy; Colleen Cowperthwait; Andrew A Nierenberg; Michael E Thase; Gary S Sachs
Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report.
The Journal of clinical psychiatry 2010;71(2):194-200.
2010: Greg Siegle; Ruth Condray; Michael E Thase; Matcheri S Keshavan; Stuart R Steinhauer
Sustained gamma-band EEG following negative words in depression and schizophrenia.
International journal of psychophysiology : official journal of the International Organization of Psychophysiology 2010;75(2):107-18.
2010: Jinbo Fan; Iuliana Ionita-Laza; Matthew B McQueen; Bernie Devlin; Shaun Purcell; Stephen V Faraone; Michael H Allen; Charles L Bowden; Joseph Calabrese; Mark D Fossey; Edward S Friedman; Laszlo Gyulai; Peter Hauser; Terence B Ketter; Lauren B Marangell; David J Miklowitz; Andrew A Nierenberg; Jayendra K Patel; Gary S Sachs; Michael E Thase; Francine B Molay; Michael Escamilla; Vishwajit L Nimgaonkar; Pamela Sklar; Nan M Laird; Jordan W Smoller
Linkage disequilibrium mapping of the chromosome 6q21-22.31 bipolar I disorder susceptibility locus.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2010;153B(1):29-37.
2010: Michael E Thase; Harald Murck; Anke Post
Clinical relevance of disturbances of sleep and vigilance in major depressive disorder: a review.
Primary care companion to the Journal of clinical psychiatry 2010;12(6):.
2010: Charlene Bryan; Thomas Songer; Maria Mori Brooks; A John Rush; Michael E Thase; Bradley N Gaynes; Balasubramani G.K.; Madhukar H Trivedi; Maurizio Fava; Stephen R Wisniewski
The impact of diabetes on depression treatment outcomes.
General hospital psychiatry 2010;32(1):33-41.
2009: Margret S H Harris; Jim Reilly; Michael E Thase; Matcheri S Keshavan; John A Sweeney
Response suppression deficits in treatment-naïve first-episode patients with schizophrenia, psychotic bipolar disorder and psychotic major depression.
Psychiatry research 2009;170(2-3):150-6.
2009: Michael E Thase
Treating major depression: antidepressant algorithms.
The Journal of clinical psychiatry 2009;70(12):e46.
2009: Andrew A Nierenberg; Louisa G Sylvia; Andrew C Leon; Noreen A Reilly-Harrington; Terence A Ketter; Joseph Calabrese; Michael E Thase; Charles L Bowden; Edward S Friedman; Michael J Ostacher; Lena Novak; Dan V Iosifescu
Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and design.
Clinical trials (London, England) 2009;6(6):637-48.
2009: Michael E Thase
Does concomitant antidepressant therapy enhance response to electroconvulsive therapy?
Current psychiatry reports 2009;11(6):423-5.
2009: Michael E Thase
Atypical depression: useful concept, but it's time to revise the DSM-IV criteria.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(13):2633-41.
2009: Michael E Thase
Pharmacotherapeutic treatment strategies for antidepressant nonresponse.
The Journal of clinical psychiatry 2009;70(11):e42.
2009: James H Kocsis; Alan J Gelenberg; Barbara O Rothbaum; Daniel N Klein; Madhukar H Trivedi; Rachel Manber; Martin B Keller; Andrew C Leon; Steven R Wisniewski; Bruce A Arnow; John Markowitz; Michael E Thase
Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial.
Archives of general psychiatry 2009;66(11):1178-88.
2009: Claudio N Soares; Susan G Kornstein; Michael E Thase; Qin Jiang; Christine J Guico-Pabia
Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials.
The Journal of clinical psychiatry 2009;70(10):1365-71.
2009: Michael E Thase
Diagnosis and treatment of a major depressive episode.
The Journal of clinical psychiatry 2009;70(10):e37.
2009: Michael E Thase
Rapid improvement in affective information processing after acute administration of reboxetine.
The American journal of psychiatry 2009;166(10):1096-9.
2009: Rachel E Maddux; Lawrence P Riso; Daniel N Klein; John C Markowitz; Barbara O Rothbaum; Bruce A Arnow; Rachel Manber; Janice A Blalock; Gabor I Keitner; Michael E Thase
Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination.
Journal of affective disorders 2009;117(3):174-9.
2009: David W Goodman; Michael E Thase
Recognizing ADHD in adults with comorbid mood disorders: implications for identification and management.
Postgraduate medicine 2009;121(5):20-30.
2009: Michael E Thase
Newer medications for complicated depression.
The Journal of clinical psychiatry 2009;70(9):e33.
2009: E Rydén; Michael E Thase; D Stråht; Anna Aberg-Wistedt; Susanne Bejerot; Mikael Landén
A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD.
Acta psychiatrica Scandinavica 2009;120(3):239-46.
2009: Sidney Zisook; Madhukar H Trivedi; Diane Warden; Barry D Lebowitz; Michael E Thase; Jonathan W Stewart; Christine Y Moutier; Maurizio Fava; Stephen R Wisniewski; James Luther; A John Rush
Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study.
Journal of affective disorders 2009;117(1-2):63-73.
2009: Maurizio Fava; Stephen R Wisniewski; Michael E Thase; Ross A Baker; Quynh-Van Tran; Andrei Pikalov; Huyuan Yang; Ronald N Marcus; Robert M Berman
Metabolic assessment of aripiprazole as adjunctive therapy in major depressive disorder: a pooled analysis of 2 studies.
Journal of clinical psychopharmacology 2009;29(4):362-7.
2009: Aaron M Koenig; Michael E Thase
First-line pharmacotherapies for depression - what is the best choice?
Polskie Archiwum Medycyny Wewnętrznej 2009;119(7-8):478-86.
2009: David J Kupfer; David Axelson; Boris Birmaher; Charlotte Brown; David E Curet; Andrea Fagiolini; Ellen Frank; Edward S Friedman; Victoria J Grochocinski; Patricia R Houck; Amy M Kilbourne; Benoit H Mulsant; Bruce G Pollock; Charles F Reynolds; Mary G Stofko; Holly A Swartz; Michael E Thase; Scott R Turkin; Ellen M Whyte
Bipolar disorder center for Pennsylvanians: implementing an effectiveness trial to improve treatment for at-risk patients.
Psychiatric services (Washington, D.C.) 2009;60(7):888-97.
2009: Roy H Perlis; Ellen B Dennehy; David J Miklowitz; Melissa P DelBello; Michael J Ostacher; Joseph Calabrese; Rebecca M Ametrano; Stephen R Wisniewski; Charles L Bowden; Michael E Thase; Andrew A Nierenberg; Gary Sachs
Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study.
Bipolar disorders 2009;11(4):391-400.
2009: Andrea Fagiolini; Ellen Frank; David Axelson; Boris Birmaher; Yu Cheng; David E Curet; Edward S Friedman; Ariel G Gildengers; Tina R Goldstein; Victoria J Grochocinski; Patricia R Houck; Mary G Stofko; Michael E Thase; Wesley K Thompson; Scott R Turkin; David J Kupfer
Enhancing outcomes in patients with bipolar disorder: results from the Bipolar Disorder Center for Pennsylvanians Study.
Bipolar disorders 2009;11(4):382-90.
2009: David Perahia; Giuseppe Maina; Michael E Thase; Melissa E Spann; Fujun Wang; Daniel J Walker; Michael Detke
Duloxetine in the prevention of depressive recurrences: a randomized, double-blind, placebo-controlled trial.
The Journal of clinical psychiatry 2009;70(5):706-16.
2009: Michael E Thase
Evaluating atypical antipsychotics in the treatment of refractory depression.
The Journal of clinical psychiatry 2009;70(5):e14.
2009: Stephen R Wisniewski; A John Rush; Andrew A Nierenberg; Bradley N Gaynes; Diane Warden; James F Luther; Patrick J McGrath; Philip W Lavori; Michael E Thase; Maurizio Fava; Madhukar H Trivedi
Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report.
The American journal of psychiatry 2009;166(5):599-607.
2009: Diane Warden; A John Rush; Stephen R Wisniewski; Ira M Lesser; Susan G Kornstein; Balasubramani G.K.; Michael E Thase; Sheldon H Preskorn; Andrew A Nierenberg; Elizabeth A Young; Kathy Shores-Wilson; Madhukar H Trivedi
What predicts attrition in second step medication treatments for depression?: a STAR*D Report.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2009;12(4):459-73.
2009: Robert M Berman; Maurizio Fava; Michael E Thase; Madhukar H Trivedi; René Swanink; Robert D McQuade; William H Carson; David Adson; Leslie Taylor; James Hazel; Ronald N Marcus
Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
CNS spectrums 2009;14(4):197-206.
2009: June Gruber; Allison G Harvey; Po W Wang; John O Brooks; Michael E Thase; Gary S Sachs; Terence A Ketter
Sleep functioning in relation to mood, function, and quality of life at entry to the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Journal of affective disorders 2009;114(1-3):41-9.
2009: Michael E Thase
Pharmacologic and therapeutic strategies in treatment-resistant depression. Augmentation strategies.
CNS spectrums 2009;14(3 Suppl 4):7-10.
2009: Michael E Thase; Susan G Kornstein; Jean-Michel Germain; Qin Jiang; Christine Guico-Pabia; Philip T Ninan
An integrated analysis of the efficacy of desvenlafaxine compared with placebo in patients with major depressive disorder.
CNS spectrums 2009;14(3):144-54.
2009: Madhukar H Trivedi; Michael E Thase; Olawale Osuntokun; David B Henley; Michael Case; Susan B Watson; Giedra M Campbell; Sara A Corya
An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
The Journal of clinical psychiatry 2009;70(3):387-96.
2009: Armin Szegedi; Wim T Jansen; Arjen P P van Willigenburg; Egbert van der Meulen; Hans H Stassen; Michael E Thase
Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients.
The Journal of clinical psychiatry 2009;70(3):344-53.
2009: David V Sheehan; Charles Nemeroff; Michael E Thase; Richard Entsuah
Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic features.
International clinical psychopharmacology 2009;24(2):61-86.
2009: James H Kocsis; Andrew C Leon; John C Markowitz; Rachel Manber; Bruce Arnow; Daniel N Klein; Michael E Thase
Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination.
The Journal of clinical psychiatry 2009;70(3):354-61.
2009: Joseph F Goldberg; John O Brooks; Keiko Kurita; Jennifer C Hoblyn; S Nassir Ghaemi; Roy H Perlis; David J Miklowitz; Terence A Ketter; Gary S Sachs; Michael E Thase
Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD.
The Journal of clinical psychiatry 2009;70(2):155-62.
2009: Joseph F Goldberg; Roy H Perlis; Charles L Bowden; Michael E Thase; David J Miklowitz; Lauren B Marangell; Joseph Calabrese; Andrew A Nierenberg; Gary S Sachs
Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD.
The American journal of psychiatry 2009;166(2):173-81.
2009: Michael E Thase
Update on partial response in depression.
The Journal of clinical psychiatry 2009;70 Suppl 6():4-9.
2009: Rachael Fleurence; Rebecca Williamson; Yonghua Jing; Edward Kim; Quynh-Van Tran; Andrei S Pikalov; Michael E Thase
A systematic review of augmentation strategies for patients with major depressive disorder.
Psychopharmacology bulletin 2009;42(3):57-90.
2009: Anthony J Rothschild; Boadie W Dunlop; David L Dunner; Edward S Friedman; Alan J Gelenberg; Peter Holland; James H Kocsis; Susan G Kornstein; Richard Shelton; Madhukar H Trivedi; John M Zajecka; Corey Goldstein; Michael E Thase; Ron Pedersen; Martin B Keller
Assessing rates and predictors of tachyphylaxis during the prevention of recurrent episodes of depression with venlafaxine ER for two years (PREVENT) study.
Psychopharmacology bulletin 2009;42(3):5-20.
2009: ALAN MALLINGER; Ellen Frank; Michael E Thase; Michelle M Barwell; Nancy Diazgranados; David Luckenbaugh; David J Kupfer
Revisiting the effectiveness of standard antidepressants in bipolar disorder: are monoamine oxidase inhibitors superior?
Psychopharmacology bulletin 2009;42(2):64-74.
2009: Mark A Demitrack; Michael E Thase
Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data.
Psychopharmacology bulletin 2009;42(2):5-38.
2009: Diane Warden; A John Rush; Stephen R Wisniewski; Ira M Lesser; Michael E Thase; Balasubramani G.K.; Kathy Shores-Wilson; Andrew A Nierenberg; Madhukar H Trivedi
Income and attrition in the treatment of depression: a STAR*D report.
Depression and anxiety 2009;26(7):622-33.
2009: Sidney H Kennedy; Henning F Andersen; Michael E Thase
Escitalopram in the treatment of major depressive disorder: a meta-analysis.
Current medical research and opinion 2009;25(1):161-75.
2008: Michael J Constantino; Joan Degeorge; Daniel N Klein; Rachel Manber; John C Markowitz; Carolina McBride; Paula Ravitz; Barbara O Rothbaum; Michael E Thase; David C Zuroff; Bruce A Arnow
Interpersonal styles of chronically depressed outpatients: Profiles and therapeutic change.
Psychotherapy (Chicago, Ill.) 2008;45(4):491-506.
2008: ALAN MALLINGER; Michael E Thase; Roger Haskett; Joan Buttenfield; David Luckenbaugh; Ellen Frank; David J Kupfer; Husseini K Manji
Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms.
Bipolar disorders 2008;10(8):856-66.
2008: Madhukar H Trivedi; Michael E Thase; Maurizio Fava; Craig J Nelson; Huyuan Yang; Ying Qi; Quynh-Van Tran; Andrei Pikalov; Berit X Carlson; Ronald N Marcus; Robert M Berman
Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
The Journal of clinical psychiatry 2008;69(12):1928-36.
2008: Michael E Thase
Do antidepressants really work? A clinicians' guide to evaluating the evidence.
Current psychiatry reports 2008;10(6):487-94.
2008: Michael E Thase
Prediction of outcome to a second trial of antidepressant medications following nonremission with citalopram therapy.
Current psychiatry reports 2008;10(6):449-51.
2008: Ellen Frank; Isabella Soreca; Holly A Swartz; Andrea Fagiolini; ALAN MALLINGER; Michael E Thase; Victoria J Grochocinski; Patricia R Houck; David J Kupfer
The role of interpersonal and social rhythm therapy in improving occupational functioning in patients with bipolar I disorder.
The American journal of psychiatry 2008;165(12):1559-65.
2008: Rif S el-Mallakh; S Nassir Ghaemi; Kemal Sagduyu; Michael E Thase; Stephen R Wisniewski; Andrew A Nierenberg; Hong Wei Zhang; Tamara A Pardo; Gary Sachs
Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients.
Journal of affective disorders 2008;111(2-3):372-7.
2008: Michael J Owens; Stan Krulewicz; Jeffrey S Simon; David V Sheehan; Michael E Thase; David J Carpenter; Susan J Plott; Charles Nemeroff
Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(13):3201-12.
2008: Michael E Thase
Maintenance therapy for bipolar disorder.
The Journal of clinical psychiatry 2008;69(11):e32.
2008: Ripu D Jindal; Raymond C Vasko; J Richard Jennings; Amy L Fasiczka; Michael E Thase; Charles F Reynolds
Heart rate variability in depressed elderly.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2008;16(11):861-6.
2008: Alan J Gelenberg; Michael E Thase; Roger E Meyer; Frederick K Goodwin; Martin M Katz; Helena Chmura Kraemer; William Z Potter; Richard C Shelton; Maurizio Fava; Arif Khan; Madhukar H Trivedi; Philip T Ninan; John J Mann; Susan Bergeson; Jean Endicott; James H Kocsis; Andrew C Leon; Husseini K Manji; Jerrold F Rosenbaum
The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies.
The Journal of clinical psychiatry 2008;69(10):1513-28.
2008: James H Kocsis; Alan J Gelenberg; Barbara O Rothbaum; Daniel N Klein; Madhukar H Trivedi; Rachel Manber; Martin B Keller; Robert Howland; Michael E Thase
Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatment.
Journal of affective disorders 2008;110(1-2):55-61.
2008: William S Gilmer; Jackie K Gollan; Stephen R Wisniewski; Robert H Howland; Madhukar H Trivedi; Sachiko Miyahara; Jenelle Fleck; Michael E Thase; Jonathan E Alpert; Andrew A Nierenberg; Diane Warden; Maurizio Fava; A John Rush
Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report.
The Journal of clinical psychiatry 2008;69(8):1246-56.
2008: J Craig Nelson; Michael E Thase; Arif Khan; J Craig Nelson
Are antidepressants effective? What's a clinician to think?
The Journal of clinical psychiatry 2008;69(6):1014-5.
2008: Rajnish Mago; Rajeev Mahajan; Michael E Thase
Medically serious adverse effects of newer antidepressants.
Current psychiatry reports 2008;10(3):249-57.
2008: Rachel Manber; Helena C Kraemer; Bruce A Arnow; Madhukar H Trivedi; A John Rush; Michael E Thase; Barbara O Rothbaum; Daniel N Klein; James H Kocsis; Alan J Gelenberg; Martin E Keller
Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone.
Journal of consulting and clinical psychology 2008;76(3):459-67.
2008: Michael E Thase; Barbara R Haight; Marty C Johnson; Thomas Hunt; Alok Krishen; Richard J Fleck; Jack G Modell
A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension.
Journal of clinical psychopharmacology 2008;28(3):302-7.
2008: Lauren B Marangell; Ellen B Dennehy; Stephen R Wisniewski; Mark S Bauer; Sachiko Miyahara; Michael Allen; Melissa Martinez; Rayan K Al Jurdi; Michael E Thase
Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD.
The Journal of clinical psychiatry 2008;69(6):916-22.
2008: Richard H Weisler; Joseph Calabrese; Michael E Thase; Robert Arvekvist; Göran Stening; Björn Paulsson; Trisha Suppes
Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studies.
The Journal of clinical psychiatry 2008;69(5):769-82.
2008: Bradley N Gaynes; A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Balasubramani G.K.; Patrick J McGrath; Michael E Thase; Michael S Klinkman; Andrew A Nierenberg; william yates; Maurizio Fava
Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D.
Journal of general internal medicine 2008;23(5):551-60.
2008: Charlene J Bryan; Thomas J Songer; Maria Mori Brooks; Michael E Thase; Bradley N Gaynes; Michael S Klinkman; john rush; Madhukar H Trivedi; Maurizio Fava; Stephen R Wisniewski
A comparison of baseline sociodemographic and clinical characteristics between major depressive disorder patients with and without diabetes: a STAR*D report.
Journal of affective disorders 2008;108(1-2):113-20.
2008: Ronald N Marcus; Robert D McQuade; William H Carson; Delphine Hennicken; Maurizio Fava; Jeffrey S Simon; Madhukar H Trivedi; Michael E Thase; Robert M Berman
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Journal of clinical psychopharmacology 2008;28(2):156-65.
2008: George I Papakostas; Maurizio Fava; Michael E Thase
Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches.
Biological psychiatry 2008;63(7):699-704.
2008: Michael E Thase
Management of patients with treatment-resistant depression.
The Journal of clinical psychiatry 2008;69(3):e8.
2008: David H Avery; Keith E Isenberg; Shirlene M Sampson; Philip G Janicak; Sarah H Lisanby; Daniel F Maixner; Colleen Loo; Michael E Thase; Mark A Demitrack; Mark Stork George
Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial.
The Journal of clinical psychiatry 2008;69(3):441-51.
2008: Christopher D Schneck; David J Miklowitz; Sachiko Miyahara; Mako Araga; Stephen Wisniewski; Laszlo Gyulai; Michael Allen; Michael E Thase; Gary S Sachs
The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD.
The American journal of psychiatry 2008;165(3):370-7; quiz 410.
2008: Charles Nemeroff; Richard Entsuah; Isma Benattia; Mark Demitrack; Diane M Sloan; Michael E Thase
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.
Biological psychiatry 2008;63(4):424-34.
2008: Michael E Thase
Quetiapine monotherapy for bipolar depression.
Neuropsychiatric disease and treatment 2008;4(1):11-21.
2008: Michael E Thase; Alan Jonas; Arif Khan; Charles L Bowden; Xiaoling Wu; Robert D McQuade; William H Carson; Ronald N Marcus; Randall Owen
Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
Journal of clinical psychopharmacology 2008;28(1):13-20.
2008: Michael E Thase
Selecting appropriate treatments for maintenance therapy for bipolar disorder.
The Journal of clinical psychiatry 2008;69 Suppl 5():28-35.
2008: Laszlo Gyulai; Mark S Bauer; Lauren B Marangell; Ellen B Dennehy; Michael E Thase; Michael W Otto; Hongwei Zhang; Stephen R Wisniewski; David J Miklowitz; Mark H Rapaport; Claudia F Baldassano; Gary S Sachs
Correlates of functioning in bipolar disorder.
Psychopharmacology bulletin 2008;41(4):51-64.
2008: Madhukar H Trivedi; James H Kocsis; Michael E Thase; David W Morris; Stephen R Wisniewski; Andrew C Leon; Alan J Gelenberg; Daniel N Klein; George Niederehe; Alan F Schatzberg; Philip T Ninan; Martin B Keller
REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and design.
Psychopharmacology bulletin 2008;41(4):5-33.
2008: Michael E Thase
Are SNRIs more effective than SSRIs? A review of the current state of the controversy.
Psychopharmacology bulletin 2008;41(2):58-85.
2008: Michael E Thase; Timothey Denko
Pharmacotherapy of mood disorders.
Annual review of clinical psychology 2008;4():53-91.
2008: David Perahia; Yili Lu Pritchett; Daniel K Kajdasz; Michael Bauer; Rakesh Jain; James M Russell; Daniel J Walker; Kimberly A Spencer; Debbie M Froud; Joel Raskin; Michael E Thase
A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
Journal of psychiatric research 2008;42(1):22-34.
2007: Martin B Keller; Madhukar H Trivedi; Michael E Thase; Richard C Shelton; Susan G Kornstein; Charles Nemeroff; Edward S Friedman; Alan J Gelenberg; James H Kocsis; David L Dunner; Boadie W Dunlop; Robert M A Hirschfeld; Anthony J Rothschild; James M Ferguson; Alan F Schatzberg; John M Zajecka; Ron Pedersen; Bing Yan; Saeeduddin Ahmed; Michael Schmidt; Philip T Ninan
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.
Biological psychiatry 2007;62(12):1371-9.
2007: Michael E Thase
Molecules that mediate mood.
The New England journal of medicine 2007;357(23):2400-2.
2007: Elisa F Cascade; Amir Kalali; Michael E Thase
Use of antidepressants: expansion beyond depression and anxiety.
Psychiatry (Edgmont (Pa. : Township)) 2007;4(12):25-8.
2007: Michael E Thase
Augmentation strategies for depression: history and concepts.
CNS spectrums 2007;12(12 Suppl 22):3-5.
2007: Michael E Thase
STEP-BD and bipolar depression: what have we learned?
Current psychiatry reports 2007;9(6):497-503.
2007: Michael E Thase
Treatment of refractory bipolar depression.
Current psychiatry reports 2007;9(6):495-6.
2007: George I Papakostas; Stuart A Montgomery; Michael E Thase; Judith R Katz; Alok Krishen; Vivian L Tucker
Comparing the rapidity of response during treatment of major depressive disorder with bupropion and the SSRIs: a pooled survival analysis of 7 double-blind, randomized clinical trials.
The Journal of clinical psychiatry 2007;68(12):1907-12.
2007: Michael E Thase; Yili Lu Pritchett; Melissa J Ossanna; Ralph W Swindle; Jimmy Xu; Michael Detke
Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder.
Journal of clinical psychopharmacology 2007;27(6):672-6.
2007: George I Papakostas; Michael E Thase; Maurizio Fava; J Craig Nelson; Richard C Shelton
Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
Biological psychiatry 2007;62(11):1217-27.
2007: Charlotte Brown; Deena R Battista; Susan M Sereika; Richard D Bruehlman; Jacqueline Dunbar-Jacob; Michael E Thase
Primary care patients' personal illness models for depression: relationship to coping behavior and functional disability.
General hospital psychiatry 2007;29(6):492-500.
2007: Paul E Keck; Mark A Frye; Michael E Thase
Bipolar depression: best practices for the hospitalized patient.
CNS spectrums 2007;12(11 Suppl 19):1-13.
2007: Stuart A Montgomery; David S Baldwin; Pierre Blier; Naomi A Fineberg; Siegfried Kasper; Malcolm Lader; Raymond Lam; Jean-Pierre Lépine; Hans-Jürgen Möller; David J Nutt; Frederic Rouillon; Alan F Schatzberg; Michael E Thase
Which antidepressants have demonstrated superior efficacy? A review of the evidence.
International clinical psychopharmacology 2007;22(6):323-9.
2007: Christine J Truman; Joseph F Goldberg; S Nassir Ghaemi; Claudia F Baldassano; Stephen R Wisniewski; Ellen B Dennehy; Michael E Thase; Gary S Sachs
Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
The Journal of clinical psychiatry 2007;68(10):1472-9.
2007: Wayne C Drevets; Michael E Thase; Eydie L Moses-Kolko; Julie Price; Ellen Frank; David J Kupfer; Chestera Mathis
Serotonin-1A receptor imaging in recurrent depression: replication and literature review.
Nuclear medicine and biology 2007;34(7):865-77.
2007: Sidney Zisook; Ira M Lesser; Jonathan W Stewart; Stephen R Wisniewski; Balasubramani G.K.; Maurizio Fava; William S Gilmer; Timothy R Dresselhaus; Michael E Thase; Andrew A Nierenberg; Madhukar H Trivedi; A John Rush
Effect of age at onset on the course of major depressive disorder.
The American journal of psychiatry 2007;164(10):1539-46.
2007: Sanjay Dubé; Gary D Tollefson; Michael E Thase; Susan D Briggs; Luann E Van Campen; Michael Case; Mauricio Tohen
Onset of antidepressant effect of olanzapine and olanzapine/fluoxetine combination in bipolar depression.
Bipolar disorders 2007;9(6):618-27.
2007: Joseph F Goldberg; Roy H Perlis; S Nassir Ghaemi; Joseph Calabrese; Charles L Bowden; Stephen R Wisniewski; David J Miklowitz; Gary S Sachs; Michael E Thase
Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD.
The American journal of psychiatry 2007;164(9):1348-55.
2007: David J Miklowitz; Michael W Otto; Ellen Frank; Noreen A Reilly-Harrington; Jane N Kogan; Gary S Sachs; Michael E Thase; Joseph Calabrese; Lauren B Marangell; Michael J Ostacher; Jayendra Patel; Marshall R Thomas; Mako Araga; Jodi Gonzalez; Stephen R Wisniewski
Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial.
The American journal of psychiatry 2007;164(9):1340-7.
2007: Martin B Keller; Madhukar H Trivedi; Michael E Thase; Richard C Shelton; Susan G Kornstein; Charles Nemeroff; Edward S Friedman; Alan J Gelenberg; James H Kocsis; David L Dunner; Robert M A Hirschfeld; Anthony J Rothschild; James M Ferguson; Alan F Schatzberg; John M Zajecka; Ronald D Pedersen; Bing Yan; Saeeduddin Ahmed; Jeff Musgnung; Philip T Ninan
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
The Journal of clinical psychiatry 2007;68(8):1246-56.
2007: Maurizio Fava; Michael E Thase; Charles DeBattista; Karl Doghramji; Sanjay Arora; Rod Hughes
Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2007;19(3):153-9.
2007: James H Kocsis; Michael E Thase; Madhukar H Trivedi; Richard C Shelton; Susan G Kornstein; Charles Nemeroff; Edward S Friedman; Alan J Gelenberg; David L Dunner; Robert M A Hirschfeld; Anthony J Rothschild; James M Ferguson; Alan F Schatzberg; John M Zajecka; Ronald D Pedersen; Bing Yan; Saeed Ahmed; Jeff Musgnung; Philip T Ninan; Martin B Keller
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study.
The Journal of clinical psychiatry 2007;68(7):1014-23.
2007: Eydie L Moses-Kolko; Julie C Price; Michael E Thase; Carolyn Meltzer; David J Kupfer; Chester A Mathis; Wendy D Bogers; Susan R Berman; Patricia R Houck; Trisha N Schneider; Wayne C Drevets
Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635.
Synapse (New York, N.Y.) 2007;61(7):523-30.
2007: Stephen R Wisniewski; Maurizio Fava; Madhukar H Trivedi; Michael E Thase; Diane Warden; George Niederehe; Edward S Friedman; Melanie Biggs; Harold A Sackeim; Kathy Shores-Wilson; Patrick J McGrath; Philip W Lavori; Sachiko Miyahara; A John Rush
Acceptability of second-step treatments to depressed outpatients: a STAR*D report.
The American journal of psychiatry 2007;164(5):753-60.
2007: Michael E Thase; Edward S Friedman; Melanie Biggs; Stephen R Wisniewski; Madhukar H Trivedi; James F Luther; Maurizio Fava; Andrew A Nierenberg; Patrick J McGrath; Diane Warden; George Niederehe; Steven D Hollon; A John Rush
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.
The American journal of psychiatry 2007;164(5):739-52.
2007: Charlotte Brown; Deena R Battista; Susan M Sereika; Richard D Bruehlman; Jacqueline Dunbar-Jacob; Michael E Thase
How can you improve antidepressant adherence?
The Journal of family practice 2007;56(5):356-63.
2007: Lisa Najavits; Melanie S Harned; Robert Gallop; Stephen F Butler; Jacques P Barber; Michael E Thase; Paul Crits-Christoph
Six-month treatment outcomes of cocaine-dependent patients with and without PTSD in a multisite national trial.
Journal of studies on alcohol and drugs 2007;68(3):353-61.
2007: Gary S Sachs; Andrew A Nierenberg; Joseph Calabrese; Lauren B Marangell; Stephen R Wisniewski; Laszlo Gyulai; Edward S Friedman; Charles L Bowden; Mark D Fossey; Michael J Ostacher; Terence A Ketter; Jayendra Patel; Peter Hauser; Daniel Rapport; James M Martinez; Michael Allen; David J Miklowitz; Michael W Otto; Ellen B Dennehy; Michael E Thase
Effectiveness of adjunctive antidepressant treatment for bipolar depression.
The New England journal of medicine 2007;356(17):1711-22.
2007: Mark Hyman Rapaport; Michael E Thase
Translating the evidence on atypical depression into clinical practice.
The Journal of clinical psychiatry 2007;68(4):e11.
2007: Jonathan W Stewart; Michael E Thase
Treating DSM-IV depression with atypical features.
The Journal of clinical psychiatry 2007;68(4):e10.
2007: David J Miklowitz; Michael W Otto; Ellen Frank; Noreen A Reilly-Harrington; Stephen R Wisniewski; Jane N Kogan; Andrew A Nierenberg; Joseph Calabrese; Lauren B Marangell; Laszlo Gyulai; Mako Araga; Jodi Gonzalez; Edwin R Shirley; Michael E Thase; Gary S Sachs
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program.
Archives of general psychiatry 2007;64(4):419-26.
2007: Charles Nemeroff; Michael E Thase
A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
Journal of psychiatric research 2007;41(3-4):351-9.
2007: Gordon B Parker; Michael E Thase
Atypical depression: a valid subtype?
The Journal of clinical psychiatry 2007;68(3):e08.
2007: Pierre Blier; Martin B Keller; Mark H Pollack; Michael E Thase; John M Zajecka; David L Dunner
Preventing recurrent depression: long-term treatment for major depressive disorder.
The Journal of clinical psychiatry 2007;68(3):e06.
2007: Michael E Thase
On the propriety of collaborations between academicians and the pharmaceutical industry: an alternate viewpoint.
World psychiatry : official journal of the World Psychiatric Association (WPA) 2007;6(1):29-31.
2007: Michael E Thase; Sara A Corya; Olawale Osuntokun; Michael Case; David B Henley; Todd M Sanger; Susan B Watson; Sanjay Dubé
A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder.
The Journal of clinical psychiatry 2007;68(2):224-36.
2007: Jonathan R T Davidson; Michael E Thase
A history of the concept of atypical depression.
The Journal of clinical psychiatry 2007;68(2):e03.
2007: Robert Gallop; Paul Crits-Christoph; Thomas R Ten Have; Jacques P Barber; Arlene Frank; Margaret L Griffin; Michael E Thase
Differential transitions between cocaine use and abstinence for men and women.
Journal of consulting and clinical psychology 2007;75(1):95-103.
2007: Kenneth A Kobak; John M Kane; Michael E Thase; Andrew A Nierenberg
Why do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms?
Journal of clinical psychopharmacology 2007;27(1):1-5.
2007: Greg Siegle; Wesley Thompson; Cameron S Carter; Stuart R Steinhauer; Michael E Thase
Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features.
Biological psychiatry 2007;61(2):198-209.
2007: Robert Ma Hirschfeld; Joseph Calabrese; Mark A Frye; Philip W Lavori; Gary Sachs; Michael E Thase; Karen Dineen Wagner
Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening.
Psychopharmacology bulletin 2007;40(3):7-14.
2007: Michael E Thase
Recognition and diagnosis of atypical depression.
The Journal of clinical psychiatry 2007;68 Suppl 8():11-6.
2007: Gavin Andrews; Traolach Brugha; Michael E Thase; Farifteh Firoozmand Duffy; Paola Rucci; Timothy Slade
Dimensionality and the category of major depressive episode.
International journal of methods in psychiatric research 2007;16 Suppl 1():S41-51.
2007: Michael E Thase
Introduction: new directions in the treatment of atypical depression.
The Journal of clinical psychiatry 2007;68 Suppl 3():4-9.
2007: Merida M Grant; Edward S Friedman; R F Haskett; Lawrence P Riso; Michael E Thase
Urinary free cortisol levels among depressed men and women: differential relationships to age and symptom severity?
Archives of women's mental health 2007;10(2):73-8.
2007: Jodi Gonzalez; Peter Thompson; Michael Escamilla; Mako Araga; Vivek Singh; Niamh Farrelly; Michael E Thase; David J Miklowitz; Charles L Bowden
Treatment characteristics and illness burden among European Americans, African Americans, and Latinos in the first 2,000 patients of the systematic treatment enhancement program for bipolar disorder.
Psychopharmacology bulletin 2007;40(1):31-46.
2007: Bruce A Arnow; Christine Blasey; Rachel Manber; Michael J Constantino; John Markowitz; Daniel N Klein; Michael E Thase; James H Kocsis; A John Rush
Dropouts versus completers among chronically depressed outpatients.
Journal of affective disorders 2007;97(1-3):197-202.
2006: Michael E Thase
New directions in the treatment of atypical depression.
The Journal of clinical psychiatry 2006;67(12):e18.
2006: Michael E Thase
The failure of evidence-based medicine to guide treatment of antidepressant nonresponders.
The Journal of clinical psychiatry 2006;67(12):1833-5.
2006: Michael E Thase
Preventing relapse and recurrence of depression: a brief review of therapeutic options.
CNS spectrums 2006;11(12 Suppl 15):12-21.
2006: Michael E Thase; Wayne Macfadden; Richard H Weisler; William Chang; Björn Paulsson; Arifulla Khan; Joseph Calabrese
Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
Journal of clinical psychopharmacology 2006;26(6):600-9.
2006: Michael E Thase
Pharmacotherapy of bipolar depression: an update.
Current psychiatry reports 2006;8(6):478-88.
2006: Michael E Thase
Head-to-head comparison of olanzapine/fluoxetine combination and lamotrigine in bipolar I depression.
Current psychiatry reports 2006;8(6):475-7.
2006: A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan W Stewart; Diane Warden; George Niederehe; Michael E Thase; Philip W Lavori; Barry D Lebowitz; Patrick J McGrath; Jerrold F Rosenbaum; Harold A Sackeim; David J Kupfer; James F Luther; Maurizio Fava
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
The American journal of psychiatry 2006;163(11):1905-17.
2006: Lauren B Marangell; Mark S Bauer; Ellen B Dennehy; Stephen R Wisniewski; Michael Allen; David J Miklowitz; Maria A Oquendo; Ellen Frank; Roy H Perlis; James M Martinez; Andrea Fagiolini; Michael W Otto; Cheryl A Chessick; Holly A Zboyan; Sachiko Miyahara; Gary Sachs; Michael E Thase
Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 years.
Bipolar disorders 2006;8(5 Pt 2):566-75.
2006: Michael E Thase; Anita H Clayton; Barbara R Haight; April H Thompson; Jack G Modell; J Andrew Johnston
A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability.
Journal of clinical psychopharmacology 2006;26(5):482-8.
2006: Patrick J McGrath; Jonathan W Stewart; Maurizio Fava; Madhukar H Trivedi; Stephen R Wisniewski; Andrew A Nierenberg; Michael E Thase; Lori Davis; Melanie Biggs; Kathy Shores-Wilson; James F Luther; George Niederehe; Diane Warden; A John Rush
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
The American journal of psychiatry 2006;163(9):1531-41; quiz 1666.
2006: Andrew A Nierenberg; Maurizio Fava; Madhukar H Trivedi; Stephen R Wisniewski; Michael E Thase; Patrick J McGrath; Jonathan E Alpert; Diane Warden; James F Luther; George Niederehe; Barry D Lebowitz; Kathy Shores-Wilson; A John Rush
A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.
The American journal of psychiatry 2006;163(9):1519-30; quiz 1665.
2006: A John Rush; Helena C Kraemer; Harold A Sackeim; Maurizio Fava; Madhukar H Trivedi; Ellen Frank; Philip T Ninan; Michael E Thase; Alan J Gelenberg; David J Kupfer; Darrel A Regier; Jerrold F Rosenbaum; Oakley Ray; Alan F Schatzberg
Report by the ACNP Task Force on response and remission in major depressive disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(9):1841-53.
2006: Maurizio Fava; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan E Alpert; Patrick J McGrath; Michael E Thase; Diane Warden; Melanie Biggs; James F Luther; George Niederehe; Louise Ritz; Madhukar H Trivedi
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.
The American journal of psychiatry 2006;163(7):1161-72.
2006: Michael E Thase; Richard C Shelton; Arifulla Khan
Treatment with venlafaxine extended release after SSRI nonresponse or intolerance: a randomized comparison of standard- and higher-dosing strategies.
Journal of clinical psychopharmacology 2006;26(3):250-8.
2006: E Friedman; Laszlo Gyulai; M Bhargava; M Landen; Stephen R Wisniewski; John M Foris; Michael J Ostacher; R Medina; Michael E Thase
Seasonal changes in clinical status in bipolar disorder: a prospective study in 1000 STEP-BD patients.
Acta psychiatrica Scandinavica 2006;113(6):510-7.
2006: S Nassir Ghaemi; Douglas J Hsu; Michael E Thase; Stephen R Wisniewski; Andrew A Nierenberg; Sachiko Miyahara; Gary Sachs
Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants.
Psychiatric services (Washington, D.C.) 2006;57(5):660-5.
2006: Hongwei Zhang; Stephen R Wisniewski; Mark S Bauer; Gary S Sachs; Michael E Thase
Comparisons of perceived quality of life across clinical states in bipolar disorder: data from the first 2000 Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) participants.
Comprehensive psychiatry 2006;47(3):161-8.
2006: Michael E Thase
Novel transdermal delivery formulation of the monoamine oxidase inhibitor selegiline nearing release for treatment of depression.
The Journal of clinical psychiatry 2006;67(4):671-2.
2006: Greg Siegle; Cameron S Carter; Michael E Thase
Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy.
The American journal of psychiatry 2006;163(4):735-8.
2006: Madhukar H Trivedi; Maurizio Fava; Stephen R Wisniewski; Michael E Thase; Frederic M Quitkin; Diane Warden; Louise Ritz; Andrew A Nierenberg; Barry D Lebowitz; Melanie Biggs; James F Luther; Kathy Shores-Wilson; A John Rush
Medication augmentation after the failure of SSRIs for depression.
The New England journal of medicine 2006;354(12):1243-52.
2006: A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Jonathan W Stewart; Andrew A Nierenberg; Michael E Thase; Louise Ritz; Melanie Biggs; Diane Warden; James F Luther; Kathy Shores-Wilson; George Niederehe; Maurizio Fava
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
The New England journal of medicine 2006;354(12):1231-42.
2006: Mark H Pollack; Naomi M Simon; Andrea Fagiolini; Roger K Pitman; Richard J McNally; Andrew A Nierenberg; Sachicko Miyahara; Gary S Sachs; Carol A Perlman; S Nassir Ghaemi; Michael E Thase; Michael W Otto
Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder.
The Journal of clinical psychiatry 2006;67(3):394-9.
2006: Mark D Fossey; Michael W Otto; william yates; Stephen R Wisniewski; Laszlo Gyulai; Michael Allen; David J Miklowitz; Kim A Coon; Michael J Ostacher; Jackie L Neel; Michael E Thase; Gary S Sachs; Roger D Weiss
Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2006;15(2):138-43.
2006: Michael E Thase
Treatment of anxiety disorders with venlafaxine XR.
Expert review of neurotherapeutics 2006;6(3):269-82.
2006: Michael E Thase
Managing depressive and anxiety disorders with escitalopram.
Expert opinion on pharmacotherapy 2006;7(4):429-40.
2006: Hadine Joffe; Deborah R Kim; John M Foris; Claudia F Baldassano; Laszlo Gyulai; Cindy H Hwang; Wren L McLaughlin; Gary S Sachs; Michael E Thase; Bernard L Harlow; Lee S Cohen
Menstrual dysfunction prior to onset of psychiatric illness is reported more commonly by women with bipolar disorder than by women with unipolar depression and healthy controls.
The Journal of clinical psychiatry 2006;67(2):297-304.
2006: Alan J Gelenberg; James H Kocsis; James P McCullough; Philip T Ninan; Michael E Thase
The state of knowledge of chronic depression.
The Journal of clinical psychiatry 2006;67(2):179-84.
2006: Michael E Thase; Maurizio Fava; Charles DeBattista; Sanjay Arora; Rod Hughes
Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study.
CNS spectrums 2006;11(2):93-102.
2006: Roy H Perlis; Michael J Ostacher; Jayendra K Patel; Lauren B Marangell; Hongwei Zhang; Stephen R Wisniewski; Terence A Ketter; David J Miklowitz; Michael W Otto; Laszlo Gyulai; Noreen A Reilly-Harrington; Andrew A Nierenberg; Gary S Sachs; Michael E Thase
Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
The American journal of psychiatry 2006;163(2):217-24.
2006: Andrew A Nierenberg; Michael J Ostacher; Joseph Calabrese; Terence A Ketter; Lauren B Marangell; David J Miklowitz; Sachiko Miyahara; Mark S Bauer; Michael E Thase; Stephen R Wisniewski; Gary S Sachs
Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
The American journal of psychiatry 2006;163(2):210-6.
2006: Mikael Landén; Michael E Thase
A model to explain the therapeutic effects of serotonin reuptake inhibitors: the role of 5-HT2 receptors.
Psychopharmacology bulletin 2006;39(1):147-66.
2006: Mark S Bauer; Stephen R Wisniewski; Jane N Kogan; Lauren B Marangell; Michael E Thase; Gary Sachs
Brief report: paroxetine in younger and adult individuals at high risk for suicide.
Psychopharmacology bulletin 2006;39(1):31-7.
2006: Michael E Thase
Bipolar depression: diagnostic and treatment considerations.
Development and psychopathology 2006;18(4):1213-30.
2006: Michael E Thase
Depression and sleep: pathophysiology and treatment.
Dialogues in clinical neuroscience 2006;8(2):217-26.
2006: Alan J Gelenberg; James H Kocsis; James P McCullough; Philip T Ninan; Michael E Thase
The state of knowledge of chronic depression.
Primary care companion to the Journal of clinical psychiatry 2006;8(2):60-5.
2006: Mark S Bauer; Stephen R Wisniewski; Lauren B Marangell; Cheryl A Chessick; Michael Allen; Ellen B Dennehy; David J Miklowitz; Michael E Thase; Gary S Sachs
Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
The Journal of clinical psychiatry 2006;67(1):48-55.
2005: Charles L Bowden; Terence A Ketter; Gary S Sachs; Michael E Thase
Focus on bipolar disorder treatment.
The Journal of clinical psychiatry 2005;66(12):1598-609.
2005: James M Martinez; Lauren B Marangell; Naomi M Simon; Sachiko Miyahara; Stephen R Wisniewski; Jennifer Harrington; Mark Pollack; Gary S Sachs; Michael E Thase
Baseline predictors of serious adverse events at one year among patients with bipolar disorder in STEP-BD.
Psychiatric services (Washington, D.C.) 2005;56(12):1541-8.
2005: Joseph F Goldberg; Michael Allen; David A Miklowitz; Charles L Bowden; Carrie J Endick; Cheryl A Chessick; Stephen R Wisniewski; Sachiko Miyahara; Kemal Sagduyu; Michael E Thase; Joseph Calabrese; Gary S Sachs
Suicidal ideation and pharmacotherapy among STEP-BD patients.
Psychiatric services (Washington, D.C.) 2005;56(12):1534-40.
2005: Charlotte Brown; Deena R Battista; Richard D Bruehlman; Susan S Sereika; Michael E Thase; Jacqueline Dunbar-Jacob
Beliefs about antidepressant medications in primary care patients: relationship to self-reported adherence.
Medical care 2005;43(12):1203-7.
2005: Michael E Thase
Bipolar depression: issues in diagnosis and treatment.
Harvard review of psychiatry 2005;13(5):257-71.
2005: Michael E Thase; Richard Entsuah; Marc Cantillon; Susan G Kornstein
Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions.
Journal of women's health (2002) 2005;14(7):609-16.
2005: Ellen Frank; David J Kupfer; Michael E Thase; ALAN MALLINGER; Holly A Swartz; Andrea Fagiolini; Victoria J Grochocinski; Patricia Houck; John Scott; Wesley Thompson; Timothy Monk
Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder.
Archives of general psychiatry 2005;62(9):996-1004.
2005: Rachel Manber; Christine Blasey; Bruce A Arnow; John Markowitz; Michael E Thase; A John Rush; Frank Dowling; James Koscis; Madhukar Trivedi; Martin B Keller
Assessing insomnia severity in depression: comparison of depression rating scales and sleep diaries.
Journal of psychiatric research 2005;39(5):481-8.
2005: Michael E Thase; Barbara R Haight; Nathalie E Richard; Carol B Rockett; Melinda Mitton; Jack G Modell; Susan VanMeter; April E Harriett; Younghua Wang
Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials.
The Journal of clinical psychiatry 2005;66(8):974-81.
2005: Gordon B Parker; Gin S Malhi; J G Crawford; Michael E Thase
Identifying "paradigm failures" contributing to treatment-resistant depression.
Journal of affective disorders 2005;87(2-3):185-91.
2005: Roger D Weiss; Michael J Ostacher; Michael W Otto; Joseph Calabrese; Mark D Fossey; Stephen R Wisniewski; Charles L Bowden; Andrew A Nierenberg; Mark H Pollack; Ihsan Salloum; Naomi M Simon; Michael E Thase; Gary S Sachs
Does recovery from substance use disorder matter in patients with bipolar disorder?
The Journal of clinical psychiatry 2005;66(6):730-5; quiz 808-9.
2005: Alan F Schatzberg; A John Rush; Bruce A Arnow; Phillip L C Banks; Janice A Blalock; Frances E Borian; Robert H Howland; Daniel N Klein; James H Kocsis; Susan G Kornstein; Rachel Manber; John Markowitz; Ivan Miller; Philip T Ninan; Barbara O Rothbaum; Michael E Thase; Madhukar H Trivedi; Martin B Keller
Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
Archives of general psychiatry 2005;62(5):513-20.
2005: Steven D Hollon; Robin B Jarrett; Andrew A Nierenberg; Michael E Thase; Madhukar Trivedi; john rush
Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment?
The Journal of clinical psychiatry 2005;66(4):455-68.
2005: Michael E Thase; Pierre V Tran; Curtis G Wiltse; Beth A Pangallo; Craig H Mallinckrodt; Michael Detke
Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine.
Journal of clinical psychopharmacology 2005;25(2):132-40.
2005: Michael E Thase
Correlates and consequences of chronic insomnia.
General hospital psychiatry 2005;27(2):100-12.
2005: Jeffery A Lieberman; Joel Greenhouse; Robert M Hamer; K Ranga Krishnan; Charles Nemeroff; David V Sheehan; Michael E Thase; Martin B Keller
Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(3):445-60.
2005: Roger D Weiss; Margaret L Griffin; Robert Gallop; Lisa Najavits; Arlene Frank; Paul Crits-Christoph; Michael E Thase; Jack Blaine; David Gastfriend; Dennis C Daley; Lester Luborsky
The effect of 12-step self-help group attendance and participation on drug use outcomes among cocaine-dependent patients.
Drug and alcohol dependence 2005;77(2):177-84.
2005: A John Rush; Madhukar H Trivedi; Thomas J Carmody; Hisham M Ibrahim; John Markowitz; Gabor I Keitner; Susan G Kornstein; Bruce A Arnow; Daniel N Klein; Rachel Manber; David L Dunner; Alan J Gelenberg; James H Kocsis; Charles Nemeroff; Jan Fawcett; Michael E Thase; James M Russell; Darlene N Jody; Frances E Borian; Martin B Keller
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(2):405-16.
2005: Hader A Mansour; Michael E Talkowski; Joel Wood; Lora Pless; Mikhil Bamne; Kodavali V Chowdari; Michael Allen; Charles L Bowden; Joseph Calabrese; Rif S el-Mallakh; Andrea Fagiolini; Stephen Faraone; Mark D Fossey; Edward S Friedman; Laszlo Gyulai; Peter Hauser; Terence A Ketter; Jennifer M Loftis; Lauren B Marangell; David J Miklowitz; Andrew A Nierenberg; Jayendra Patel; Gary S Sachs; Pamela Sklar; Jordan W Smoller; Michael E Thase; Ellen Frank; David J Kupfer; Vishwajit L Nimgaonkar
Serotonin gene polymorphisms and bipolar I disorder: focus on the serotonin transporter.
Annals of medicine 2005;37(8):590-602.
2005: Hader A Mansour; Joel Wood; Kodavali V Chowdari; Madhulika Dayal; Michael E Thase; David J Kupfer; Timothy H Monk; Bernie Devlin; Vishwajit L Nimgaonkar
Circadian phase variation in bipolar I disorder.
Chronobiology international 2005;22(3):571-84.
2005: Maurizio Fava; A John Rush; Michael E Thase; Anita Clayton; Stephen M Stahl; James F Pradko; J Andrew Johnston
15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL.
Primary care companion to the Journal of clinical psychiatry 2005;7(3):106-13.
2005: Mikael Landén; Per Högberg; Michael E Thase
Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine.
The Journal of clinical psychiatry 2005;66(1):100-6.
2005: Maurizio Fava; Michael E Thase; Charles DeBattista
A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.
The Journal of clinical psychiatry 2005;66(1):85-93.
2005: Ihsan Salloum; Jack R Cornelius; Dennis C Daley; Levent Kirisci; Jonathan M Himmelhoch; Michael E Thase
Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
Archives of general psychiatry 2005;62(1):37-45.
2004: Naomi M Simon; Michael W Otto; Stephen R Wisniewski; Mark D Fossey; Kemal Sagduyu; Ellen Frank; Gary S Sachs; Andrew A Nierenberg; Michael E Thase; Mark H Pollack
Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
The American journal of psychiatry 2004;161(12):2222-9.
2004: Jane N Kogan; Michael W Otto; Mark S Bauer; Ellen B Dennehy; David J Miklowitz; Hong-Wei Zhang; Terence A Ketter; Matthew V Rudorfer; Stephen R Wisniewski; Michael E Thase; Joseph Calabrese; Gary S Sachs
Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Bipolar disorders 2004;6(6):460-9.
2004: Michael E Thase
Therapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence.
CNS spectrums 2004;9(11):808-16, 818-21.
2004: Arif Khan; Russell L Kolts; Michael E Thase; K Ranga Rama Krishnan; Walter Brown
Research design features and patient characteristics associated with the outcome of antidepressant clinical trials.
The American journal of psychiatry 2004;161(11):2045-9.
2004: Lewis L Judd; Mark Hyman Rapaport; Kimberly A Yonkers; A John Rush; Ellen Frank; Michael E Thase; David J Kupfer; John M Plewes; Pamela J Schettler; Gary Tollefson
Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder.
The American journal of psychiatry 2004;161(10):1864-71.
2004: Naomi M Simon; Michael W Otto; Roger D Weiss; Mark S Bauer; Sachiko Miyahara; Stephen R Wisniewski; Michael E Thase; Jane N Kogan; Ellen Frank; Andrew A Nierenberg; Joseph Calabrese; Gary S Sachs; Mark H Pollack
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.
Journal of clinical psychopharmacology 2004;24(5):512-20.
2004: Lynne Siqueland; Paul Crits-Christoph; Jacques P Barber; Mary Beth Connolly Gibbons; Robert Gallop; Margaret Griffin; Arlene Frank; Michael E Thase; Lester Luborsky; Bruce Liese
What aspects of treatment matter to the patient in the treatment of cocaine dependence?
Journal of substance abuse treatment 2004;27(2):169-78.
2004: Alan J Gelenberg; Richard C Shelton; Paul Crits-Christoph; Martin B Keller; David L Dunner; Robert M A Hirschfeld; Michael E Thase; James M Russell; R Bruce Lydiard; Robert Gallop; Linda Todd; David J Hellerstein; Paul J Goodnick; Gabor I Keitner; Stephen M Stahl; Uriel Halbreich; Heather S Hopkins
The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication.
The Journal of clinical psychiatry 2004;65(8):1114-9.
2004: Daniel N Klein; Neil J Santiago; Dina Vivian; Janice A Blalock; James H Kocsis; John Markowitz; James P McCullough Jr; A John Rush; Madhukar H Trivedi; Bruce A Arnow; David L Dunner; Rachel Manber; Barbara O Rothbaum; Michael E Thase; Gabor I Keitner; Ivan W Miller; Martin B Keller
Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression.
Journal of consulting and clinical psychology 2004;72(4):681-8.
2004: S Kristian Hill; Matcheri S Keshavan; Michael E Thase; John A Sweeney
Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression.
The American journal of psychiatry 2004;161(6):996-1003.
2004: Andrew A Nierenberg; Frederic M Quitkin; Charlotte Kremer; Martin B Keller; Michael E Thase
Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapse.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(5):1012-8.
2004: Holly A Swartz; Ellen Frank; M Katherine Shear; Michael E Thase; M A Dana Fleming; John Scott
A pilot study of brief interpersonal psychotherapy for depression among women.
Psychiatric services (Washington, D.C.) 2004;55(4):448-50.
2004: Lauren B Marangell; James M Martinez; Terence A Ketter; Charles L Bowden; Joseph F Goldberg; Joseph Calabrese; Sachiko Miyahara; David J Miklowitz; Gary S Sachs; Michael E Thase
Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD.
Bipolar disorders 2004;6(2):139-43.
2004: Anna Lembke; David J Miklowitz; Michael W Otto; Hongwei Zhang; Stephen R Wisniewski; Gary S Sachs; Michael E Thase; Terence A Ketter
Psychosocial service utilization by patients with bipolar disorders: data from the first 500 participants in the Systematic Treatment Enhancement Program.
Journal of psychiatric practice 2004;10(2):81-7.
2004: Greg Siegle; Stuart R Steinhauer; Michael E Thase
Pupillary assessment and computational modeling of the Stroop task in depression.
International journal of psychophysiology : official journal of the International Organization of Psychophysiology 2004;52(1):63-76.
2004: Ripu D Jindal; Michael E Thase
Treatment of insomnia associated with clinical depression.
Sleep medicine reviews 2004;8(1):19-30.
2004: A John Rush; Maurizio Fava; Stephen R Wisniewski; Philip W Lavori; Madhukar H Trivedi; Harold A Sackeim; Michael E Thase; Andrew A Nierenberg; Frederic M Quitkin; T Michael Kashner; David J Kupfer; Jerrold F Rosenbaum; Jonathan Alpert; Jonathan W Stewart; Patrick J McGrath; Melanie Biggs; Kathy Shores-Wilson; Barry D Lebowitz; Louise Ritz; George Niederehe
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.
Controlled clinical trials 2004;25(1):119-42.
2004: Michael E Thase
Introduction: the dual-action debate: does pharmacology matter?
The Journal of clinical psychiatry 2004;65 Suppl 17():3-4.
2004: Ripu D Jindal; Daniel J Buysse; Michael E Thase
Maintenance treatment of insomnia: what can we learn from the depression literature?
The American journal of psychiatry 2004;161(1):19-24.
2003: Ripu D Jindal; Edward S Friedman; Susan R Berman; Amy L Fasiczka; Robert H Howland; Michael E Thase
Effects of sertraline on sleep architecture in patients with depression.
Journal of clinical psychopharmacology 2003;23(6):540-8.
2003: Bruce A Arnow; Rachel Manber; Christine Blasey; Daniel N Klein; Janice A Blalock; John Markowitz; Barbara O Rothbaum; A John Rush; Michael E Thase; Lawrence P Riso; Dina Vivian; James P McCullough; Martin B Keller
Therapeutic reactance as a predictor of outcome in the treatment of chronic depression.
Journal of consulting and clinical psychology 2003;71(6):1025-35.
2003: Daniel N Klein; Joseph E Schwartz; Neil J Santiago; Dina Vivian; Carina Vocisano; Louis G Castonguay; Bruce A Arnow; Janice A Blalock; Rachel Manber; John Markowitz; Lawrence P Riso; Barbara O Rothbaum; James P McCullough; Michael E Thase; Frances E Borian; Ivan W Miller; Martin B Keller
Therapeutic alliance in depression treatment: controlling for prior change and patient characteristics.
Journal of consulting and clinical psychology 2003;71(6):997-1006.
2003: Charles Nemeroff; Christine Heim; Michael E Thase; Daniel N Klein; A John Rush; Alan F Schatzberg; Philip T Ninan; James P McCullough; Paul M Weiss; David L Dunner; Barbara O Rothbaum; Susan G Kornstein; Gabor I Keitner; Martin B Keller
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(24):14293-6.
2003: Zindel V Segal; Jane L Pearson; Michael E Thase
Challenges in preventing relapse in major depression. Report of a National Institute of Mental Health Workshop on state of the science of relapse prevention in major depression.
Journal of affective disorders 2003;77(2):97-108.
2003: Ripu D Jindal; Michael E Thase
Integrating psychotherapy and pharmacotherapy to improve outcomes among patients with mood disorders.
Psychiatric services (Washington, D.C.) 2003;54(11):1484-90.
2003: Alan J Gelenberg; Madhukar H Trivedi; A John Rush; Michael E Thase; Robert H Howland; Daniel N Klein; Susan G Kornstein; David L Dunner; John Markowitz; Robert M A Hirschfeld; Gabor I Keitner; John M Zajecka; James H Kocsis; James M Russell; Ivan Miller; Rachel Manber; Bruce A Arnow; Barbara O Rothbaum; Melvin Munsaka; Phillip Banks; Frances E Borian; Martin B Keller
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
Biological psychiatry 2003;54(8):806-17.
2003: Paul Crits-Christoph; Mary Beth Connolly Gibbons; Jacques P Barber; Robert Gallop; Aaron T Beck; Delinda Mercer; Xin Tu; Michael E Thase; Roger D Weiss; Arlene Frank
Mediators of outcome of psychosocial treatments for cocaine dependence.
Journal of consulting and clinical psychology 2003;71(5):918-25.
2003: Lisa Najavits; Ragna Runkel; Christina Neuner; Arlene F Frank; Michael E Thase; Paul Crits-Christoph; Jack Blaine
Rates and symptoms of PTSD among cocaine-dependent patients.
Journal of studies on alcohol 2003;64(5):601-6.
2003: A John Rush; Madhukar H Trivedi; Hisham M Ibrahim; Thomas J Carmody; Bruce A Arnow; Daniel N Klein; John Markowitz; Philip T Ninan; Susan G Kornstein; Rachel Manber; Michael E Thase; James H Kocsis; Martin B Keller
The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.
Biological psychiatry 2003;54(5):573-83.
2003: Gary S Sachs; Michael E Thase; Michael W Otto; Mark Bauer; David J Miklowitz; Stephen R Wisniewski; Philip W Lavori; Barry Lebowitz; Matthew V Rudorfer; Ellen Frank; Andrew A Nierenberg; Maurizio Fava; Charles L Bowden; Terence A Ketter; Lauren B Marangell; Joseph Calabrese; David Kupfer; Jerrold F Rosenbaum
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).
Biological psychiatry 2003;53(11):1028-42.
2003: Michael E Thase; Manoj Bhargava; Gary S Sachs
Treatment of bipolar depression: current status, continued challenges, and the STEP-BD approach.
The Psychiatric clinics of North America 2003;26(2):495-518.
2003: Maurizio Fava; A John Rush; Madhukar H Trivedi; Andrew A Nierenberg; Michael E Thase; Harold A Sackeim; Frederic M Quitkin; Steven Wisniewski; Philip W Lavori; Jerrold F Rosenbaum; David J Kupfer
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.
The Psychiatric clinics of North America 2003;26(2):457-94, x.
2003: Rachel Manber; Bruce A Arnow; Christine Blasey; Dina Vivian; James P McCullough; Janice A Blalock; Daniel N Klein; John Markowitz; Lawrence P Riso; Barbara O Rothbaum; A John Rush; Michael E Thase; Martin B Keller
Patient's therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication.
Psychological medicine 2003;33(4):693-702.
2003: Joseph Calabrese; Peter D Londborg; Melvin D Shelton; Michael E Thase
Citalopram treatment of fluoxetine-intolerant depressed patients.
The Journal of clinical psychiatry 2003;64(5):562-7.
2003: David Healy; Michael E Thase
Is academic psychiatry for sale?
The British journal of psychiatry : the journal of mental science 2003;182():388-90.
2003: A John Rush; Michael E Thase; Sanjay Dubé
Research issues in the study of difficult-to-treat depression.
Biological psychiatry 2003;53(8):743-53.
2003: Greg Siegle; Roma O Konecky; Michael E Thase; Cameron S Carter
Relationships between amygdala volume and activity during emotional information processing tasks in depressed and never-depressed individuals: an fMRI investigation.
Annals of the New York Academy of Sciences 2003;985():481-4.
2003: Rachel Manber; A John Rush; Michael E Thase; Bruce Amow; Dan Klein; Madhukar H Trivedi; Susan G Korenstein; John Markowitz; David L Dunner; Melvin Munsaka; Frances E Borian; B Keller
The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression.
Sleep 2003;26(2):130-6.
2003: Michael E Thase
Achieving remission and managing relapse in depression.
The Journal of clinical psychiatry 2003;64 Suppl 18():3-7.
2003: Michael E Thase
Treatment of recurrent depression: an alternate viewpoint.
CNS drugs 2003;17(15):1119-22.
2003: Ripu D Jindal; Amy L Fasiczka; Jonathan M Himmelhoch; ALAN MALLINGER; Michael E Thase
Effects of tranylcypromine on the sleep of patients with anergic bipolar depression.
Psychopharmacology bulletin 2003;37(3):118-26.
2003: Michael E Thase
Evaluating antidepressant therapies: remission as the optimal outcome.
The Journal of clinical psychiatry 2003;64 Suppl 13():18-25.
2003: Michael E Thase
New approaches to managing difficult-to-treat depressions.
The Journal of clinical psychiatry 2003;64 Suppl 1():3-4.
2003: Michael E Thase
Effectiveness of antidepressants: comparative remission rates.
The Journal of clinical psychiatry 2003;64 Suppl 2():3-7.
2002: Ellen Frank; Jill M Cyranowski; Paola Rucci; M Katherine Shear; Andrea Fagiolini; Michael E Thase; Giovanni B Cassano; Victoria J Grochocinski; Bryan Kostelnik; David J Kupfer
Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder.
Archives of general psychiatry 2002;59(10):905-11.
2002: Yookyung Kim; Paul A Pilkonis; Ellen Frank; Michael E Thase; Charles F Reynolds
Differential functioning of the Beck depression inventory in late-life patients: use of item response theory.
Psychology and aging 2002;17(3):379-91.
2002: John M Zajecka; David L Dunner; Alan J Gelenberg; Robert M A Hirschfeld; Susan G Kornstein; Philip T Ninan; A John Rush; Michael E Thase; Madhukar H Trivedi; Bruce A Arnow; Frances E Borian; Rachel Manber; Martin B Keller
Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination.
The Journal of clinical psychiatry 2002;63(8):709-16.
2002: Stuart A Montgomery; Per Bech; Pierre Blier; Hans-Jürgen Möller; Andrew A Nierenberg; Roger M Pinder; Frederic M Quitkin; Paul-Egbert Reimitz; Jerrold F Rosenbaum; john rush; H H Stassen; Michael E Thase
Selecting methodologies for the evaluation of differences in time to response between antidepressants.
The Journal of clinical psychiatry 2002;63(8):694-9.
2002: Lawrence P Riso; Ronald K Miyatake; Michael E Thase
The search for determinants of chronic depression: a review of six factors.
Journal of affective disorders 2002;70(2):103-15.
2002: Paola Rucci; Ellen Frank; Bryan Kostelnik; Andrea Fagiolini; ALAN MALLINGER; Holly A Swartz; Michael E Thase; Lori Siegel; Dorothy Wilson; David J Kupfer
Suicide attempts in patients with bipolar I disorder during acute and maintenance phases of intensive treatment with pharmacotherapy and adjunctive psychotherapy.
The American journal of psychiatry 2002;159(7):1160-4.
2002: Michael E Thase; A John Rush; Rachel Manber; Susan G Kornstein; Daniel N Klein; John Markowitz; Philip T Ninan; Edward S Friedman; David L Dunner; Alan F Schatzberg; Frances E Borian; Madhukar H Trivedi; Martin B Keller
Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression.
The Journal of clinical psychiatry 2002;63(6):493-500.
2002: Philip T Ninan; A John Rush; Paul Crits-Christoph; Susan G Kornstein; Rachel Manber; Michael E Thase; Madhukar H Trivedi; Barbara O Rothbaum; John M Zajecka; Frances E Borian; Martin B Keller
Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
The Journal of clinical psychiatry 2002;63(5):434-41.
2002: Greg Siegle; Stuart R Steinhauer; Michael E Thase; V Andrew Stenger; Cameron S Carter
Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals.
Biological psychiatry 2002;51(9):693-707.
2002: Mark Hyman Rapaport; Lewis L Judd; Pamela J Schettler; Kimberly A Yonkers; Michael E Thase; David J Kupfer; Ellen Frank; John M Plewes; Gary D Tollefson; A John Rush
A descriptive analysis of minor depression.
The American journal of psychiatry 2002;159(4):637-43.
2002: donald klein; Michael E Thase; Jean Endicott; Lawrence Adler; Ira Glick; Amir Kalali; Steven Leventer; Jeffrey Mattes; Peter Ross; Alexander Bystritsky
Improving clinical trials: American Society of Clinical Psychopharmacology recommendations.
Archives of general psychiatry 2002;59(3):272-8.
2002: Michael E Thase; A John Rush; Robert H Howland; Susan G Kornstein; James H Kocsis; Alan J Gelenberg; Alan F Schatzberg; Lorrin M Koran; Martin B Keller; James M Russell; Robert M A Hirschfeld; Lisa M LaVange; Daniel N Klein; Jan Fawcett; Wilma Harrison
Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression.
Archives of general psychiatry 2002;59(3):233-9.
2002: Michael E Thase
What role do atypical antipsychotic drugs have in treatment-resistant depression?
The Journal of clinical psychiatry 2002;63(2):95-103.
2002: Ripu D Jindal; Michael E Thase; Amy L Fasiczka; Edward S Friedman; Daniel J Buysse; Ellen Frank; David J Kupfer
Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression: II. Comparison during remission.
Biological psychiatry 2002;51(3):230-6.
2002: Robert M A Hirschfeld; David L Dunner; Gabor I Keitner; Daniel N Klein; Lorrin M Koran; Susan G Kornstein; John Markowitz; Ivan Miller; Charles Nemeroff; Philip T Ninan; A John Rush; Alan F Schatzberg; Michael E Thase; Madhukar H Trivedi; Frances E Borian; Paul Crits-Christoph; Martin B Keller
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination.
Biological psychiatry 2002;51(2):123-33.
2002: Michael E Thase
Studying new antidepressants: if there were a light at the end of the tunnel, could we see it?
The Journal of clinical psychiatry 2002;63 Suppl 2():24-8.
2002: Susan G Kornstein; Diane M E Sloan; Michael E Thase
Gender-specific differences in depression and treatment response.
Psychopharmacology bulletin 2002;36(4 Suppl 3):99-112.
2002: Michael E Thase; Diane M E Sloan; Susan G Kornstein
Remission as the critical outcome of depression treatment.
Psychopharmacology bulletin 2002;36(4 Suppl 3):12-25.
2002: Susan G Kornstein; Diane M E Sloan; Michael E Thase
Gender-specific differences in depression and treatment response.
Psychopharmacology bulletin 2002;36(4):99-112.
2002: Michael E Thase; Diane M E Sloan; Susan G Kornstein
Remission as the critical outcome of depression treatment.
Psychopharmacology bulletin 2002;36(4):12-25.
2002: Michael E Thase
The next step forward: a move toward evidence, and away from fear of the industry.
Psychopharmacology bulletin 2002;36(4):4-5.
2002: Michael E Thase; Madhukar Trivedi
Optimizing treatment outcomes for patients with depression and generalized anxiety disorder.
Psychopharmacology bulletin 2002;36 Suppl 2():93-102.
2002: Michael E Thase; Philip T Ninan
New goals in the treatment of depression: moving toward recovery.
Psychopharmacology bulletin 2002;36 Suppl 2():24-35.
2002: Michael E Thase; James M Ferguson; R Bruce Lydiard; Charles S Wilcox
Citalopram treatment of paroxetine-intolerant depressed patients.
Depression and anxiety 2002;16(3):128-33.
2002: Michael E Thase
Comparing the methods used to compare antidepressants.
Psychopharmacology bulletin 2002;36 Suppl 1():Suppl 1-17; quiz Suppl 18-9.
2002: Lynne Siqueland; Paul Crits-Christoph; Robert Gallop; Jacques P Barber; Margaret L Griffin; Michael E Thase; Dennis C Daley; Arlene Frank; David Gastfriend; Jack Blaine; Mary Beth Connolly; Madeline Gladis
Retention in psychosocial treatment of cocaine dependence: predictors and impact on outcome.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2002;11(1):24-40.
2002: Daniel P Cole; Michael E Thase; ALAN MALLINGER; Jair C Soares; James F Luther; David J Kupfer; Ellen Frank
Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function.
The American journal of psychiatry 2002;159(1):116-21.
2001: Philip W Lavori; john rush; Stephen R Wisniewski; Jonathan Alpert; M Fava; D J Kupfer; Andrew A Nierenberg; Frederic M Quitkin; Harold A Sackeim; Michael E Thase; Madhukar Trivedi
Strengthening clinical effectiveness trials: equipoise-stratified randomization.
Biological psychiatry 2001;50(10):792-801.
2001: Michael E Thase; Andrew A Nierenberg; Martin B Keller; J Panagides
Efficacy of mirtazapine for prevention of depressive relapse: a placebo-controlled double-blind trial of recently remitted high-risk patients.
The Journal of clinical psychiatry 2001;62(10):782-8.
2001: Paul Crits-Christoph; Lynne Siqueland; E McCalmont; Roger D Weiss; David Gastfriend; Arlene Frank; Karla Moras; Jacques P Barber; Jack Blaine; Michael E Thase
Impact of psychosocial treatments on associated problems of cocaine-dependent patients.
Journal of consulting and clinical psychology 2001;69(5):825-30.
2001: Michael E Thase; J P Feighner; R Bruce Lydiard
Citalopram treatment of fluoxetine nonresponders.
The Journal of clinical psychiatry 2001;62(9):683-7.
2001: Michael E Thase
Neuroimaging profiles and the differential therapies of depression.
Archives of general psychiatry 2001;58(7):651-3.
2001: Lorrin M Koran; Alan J Gelenberg; Susan G Kornstein; Robert H Howland; R A Friedman; Charles DeBattista; D Klein; James H Kocsis; Alan F Schatzberg; Michael E Thase; A John Rush; Robert M A Hirschfeld; Lisa M LaVange; Martin B Keller
Sertraline versus imipramine to prevent relapse in chronic depression.
Journal of affective disorders 2001;65(1):27-36.
2001: Charlotte Brown; Jacqueline Dunbar-Jacob; D R Palenchar; K J Kelleher; Richard D Bruehlman; Susan M Sereika; Michael E Thase
Primary care patients' personal illness models for depression: a preliminary investigation.
Family practice 2001;18(3):314-20.
2001: Richard C Shelton; Martin B Keller; Alan J Gelenberg; David L Dunner; Robert M A Hirschfeld; Michael E Thase; J Russell; R Bruce Lydiard; P Crits-Cristoph; Robert Gallop; L Todd; David J Hellerstein; Paul J Goodnick; Gabor I Keitner; Stephen M Stahl; Uriel Halbreich
Effectiveness of St John's wort in major depression: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2001;285(15):1978-86.
2001: Eric A Nofzinger; S Berman; Amy L Fasiczka; Jean M Miewald; Carolyn Meltzer; Julie C Price; Robert C Sembrat; Annette Wood; Michael E Thase
Effects of bupropion SR on anterior paralimbic function during waking and REM sleep in depression: preliminary findings using.
Psychiatry research 2001;106(2):95-111.
2001: Harold A Sackeim; Roger F Haskett; Benoit H Mulsant; Michael E Thase; J John Mann; H M Pettinati; RM Greenberg; R R Crowe; T B Cooper; Joan Prudic
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2001;285(10):1299-307.
2001: Michael E Thase; A R Entsuah; R L Rudolph
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.
The British journal of psychiatry : the journal of mental science 2001;178():234-41.
2001: Jacques P Barber; Lester Luborsky; Robert Gallop; Paul Crits-Christoph; Arlene Frank; Roger D Weiss; Michael E Thase; Mary Beth Connolly; Madeline Gladis; Carol Foltz; Lynne Siqueland
Therapeutic alliance as a predictor of outcome and retention in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study.
Journal of consulting and clinical psychology 2001;69(1):119-24.
2001: R Taylor; ALAN MALLINGER; Ellen Frank; P Rucci; Michael E Thase; David J Kupfer
Variability of erythrocyte and serum lithium levels correlates with therapist treatment adherence efforts and maintenance treatment outcome.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;24(2):192-7.
2001: Michael E Thase; Ihsan Salloum; J D Cornelius
Comorbid alcoholism and depression: treatment issues.
The Journal of clinical psychiatry 2001;62 Suppl 20():32-41.
2001: Michael E Thase; Edward S Friedman; Robert H Howland
Management of treatment-resistant depression: psychotherapeutic perspectives.
The Journal of clinical psychiatry 2001;62 Suppl 18():18-24.
2001: Michael E Thase
Methodology to measure onset of action.
The Journal of clinical psychiatry 2001;62 Suppl 15():18-21.
2000: K N Roy Chengappa; Mauricio Tohen; Joseph Levine; T Jacobs; Michael E Thase; Todd M Sanger; David J Kupfer
Response to placebo among bipolar I disorder patients experiencing their first manic episode.
Bipolar disorders 2000;2(4):332-5.
2000: Eric A Nofzinger; Amy L Fasiczka; S Berman; Michael E Thase
Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder.
The Journal of clinical psychiatry 2000;61(11):858-62.
2000: Susan G Kornstein; Alan F Schatzberg; Michael E Thase; Kimberly A Yonkers; James P McCullough; Gabor I Keitner; Alan J Gelenberg; Christine E Ryan; A L Hess; Wilma Harrison; Sonia M Davis; Martin B Keller
Gender differences in chronic major and double depression.
Journal of affective disorders 2000;60(1):1-11.
2000: Gary S Sachs; Michael E Thase
Bipolar disorder therapeutics: maintenance treatment.
Biological psychiatry 2000;48(6):573-81.
2000: Michael E Thase; Gary S Sachs
Bipolar depression: pharmacotherapy and related therapeutic strategies.
Biological psychiatry 2000;48(6):558-72.
2000: Ihsan Salloum; Michael E Thase
Impact of substance abuse on the course and treatment of bipolar disorder.
Bipolar disorders 2000;2(3 Pt 2):269-80.
2000: Susan G Kornstein; Alan F Schatzberg; Michael E Thase; Kimberly A Yonkers; James P McCullough; Gabor I Keitner; Alan J Gelenberg; Sonia M Davis; Wilma M Harrison; Martin B Keller
Gender differences in treatment response to sertraline versus imipramine in chronic depression.
The American journal of psychiatry 2000;157(9):1445-52.
2000: James P McCullough; Daniel N Klein; Martin B Keller; Charles Holzer; Sonia M Davis; Susan G Kornstein; Robert H Howland; Michael E Thase; Wilma M Harrison
Comparison of DSM-III-R chronic major depression and major depression superimposed on dysthymia (double depression): validity of the distinction.
Journal of abnormal psychology 2000;109(3):419-27.
2000: Michael E Thase; Edward S Friedman; Amy L Fasiczka; Susan R Berman; Ellen Frank; Eric A Nofzinger; Charles F Reynolds
Treatment of men with major depression: a comparison of sequential cohorts treated with either cognitive-behavioral therapy or newer generation antidepressants.
The Journal of clinical psychiatry 2000;61(7):466-72.
2000: Martin B Keller; James P McCullough; Daniel N Klein; Bruce A Arnow; David L Dunner; Alan J Gelenberg; John Markowitz; Charles Nemeroff; James M Russell; Michael E Thase; Madhukar H Trivedi; John M Zajecka
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.
The New England journal of medicine 2000;342(20):1462-70.
2000: Jack R Cornelius; Ihsan Salloum; Roger F Haskett; Dennis C Daley; Marie D Cornelius; Michael E Thase; James M Perel
Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study.
Addictive behaviors 2000;25(2):307-10.
2000: Michael E Thase; Edward S Friedman; Robert H Howland
Venlafaxine and treatment-resistant depression.
Depression and anxiety 2000;12 Suppl 1():55-62.
2000: Michael E Thase
Treatment issues related to sleep and depression.
The Journal of clinical psychiatry 2000;61 Suppl 11():46-50.
2000: Lynne Siqueland; Paul Crits-Christoph; Jacques P Barber; Stephen F Butler; Michael E Thase; Lisa Najavits; LS Onken
The role of therapist characteristics in training effects in cognitive, supportive-expressive, and drug counseling therapies for cocaine dependence.
The Journal of psychotherapy practice and research 2000;9(3):123-30.
2000: Michael E Thase; Edward S Friedman; Susan R Berman; Amy L Fasiczka; J A Lis; Robert H Howland; AD Simons
Is cognitive behavior therapy just a 'nonspecific' intervention for depression? A retrospective comparison of consecutive cohorts treated with cognitive behavior therapy or supportive counseling and pill placebo.
Journal of affective disorders 2000;57(1-3):63-71.
2000: Michael E Thase
Treatment of severe depression.
The Journal of clinical psychiatry 2000;61 Suppl 1():17-25.
1999: James D Tew; Benoit H Mulsant; Roger F Haskett; Joan Prudic; Michael E Thase; R R Crowe; Diane Dolata; Amy E Begley; Charles F Reynolds; Harold A Sackeim
Acute efficacy of ECT in the treatment of major depression in the old-old.
The American journal of psychiatry 1999;156(12):1865-70.
1999: Ellen Frank; Holly A Swartz; ALAN MALLINGER; Michael E Thase; E V Weaver; David J Kupfer
Adjunctive psychotherapy for bipolar disorder: effects of changing treatment modality.
Journal of abnormal psychology 1999;108(4):579-87.
1999: Daniel N Klein; Alan F Schatzberg; James P McCullough; F Dowling; D Goodman; Robert H Howland; John Markowitz; C Smith; Michael E Thase; A John Rush; Lisa M LaVange; Wilma M Harrison; Martin B Keller
Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response.
Journal of affective disorders 1999;55(2-3):149-57.
1999: Oommen K Mammen; M Katherine Shear; Paul A Pilkonis; David J Kolko; Michael E Thase; Catherine G Greeno
Anger attacks: correlates and significance of an underrecognized symptom.
The Journal of clinical psychiatry 1999;60(9):633-42; quiz 643.
1999: John A Sweeney; Beatriz Luna; Gretchen L Haas; Matcheri S Keshavan; J John Mann; Michael E Thase
Pursuit tracking impairments in schizophrenia and mood disorders: step-ramp studies with unmedicated patients.
Biological psychiatry 1999;46(5):671-80.
1999: Michael E Thase
Psychotherapy of depression: current status, future directions.
CNS spectrums 1999;4(7):62-6.
1999: Michael E Thase; Edward S Friedman
Is psychotherapy an effective treatment for melancholia and other severe depressive states?
Journal of affective disorders 1999;54(1-2):1-19.
1999: Paul Crits-Christoph; Lynne Siqueland; Jack Blaine; Arlene Frank; Lester Luborsky; LS Onken; Larry R Muenz; Michael E Thase; Roger D Weiss; David Gastfriend; George E Woody; Jacques P Barber; Stephen F Butler; Dennis C Daley; Ihsan Salloum; S Bishop; Lisa Najavits; Judy Lis; Delinda Mercer; Margaret L Griffin; Karla Moras; Aaron T Beck
Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study.
Archives of general psychiatry 1999;56(6):493-502.
1999: Elisha P Merriam; Michael E Thase; Gretchen L Haas; Matcheri S Keshavan; John A Sweeney
Prefrontal cortical dysfunction in depression determined by Wisconsin Card Sorting Test performance.
The American journal of psychiatry 1999;156(5):780-2.
1999: Michael E Thase
Summary: defining remission in patients treated with antidepressants.
The Journal of clinical psychiatry 1999;60 Suppl 22():35-6.
1999: Michael E Thase
Introduction: defining remission in patients treated with antidepressants.
The Journal of clinical psychiatry 1999;60 Suppl 22():3-6.
1999: S Hamilton; Lisa A Mellman; G O Gabbard; Michael E Thase; John Markowitz
Psychotherapies in residency training.
The Journal of psychotherapy practice and research 1999;8(4):302-13.
1999: Michael E Thase
Antidepressant treatment of the depressed patient with insomnia.
The Journal of clinical psychiatry 1999;60 Suppl 17():28-31; discussion 46-8.
1999: Michael E Thase
Long-term nature of depression.
The Journal of clinical psychiatry 1999;60 Suppl 14():3-9; discussion 31-5.
1999: Lynne Siqueland; A Horn; Karla Moras; George E Woody; R Weiss; Jack Blaine; S Bishop; J Barber; Michael E Thase
Cocaine-induced mood disorder: prevalence rates and psychiatric symptoms in an outpatient cocaine-dependent sample.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 1999;8(2):165-9.
1999: Patricia A Cluss; S C Marcus; K J Kelleher; Michael E Thase; L A Arvay; David J Kupfer
Diagnostic certainty of a voluntary bipolar disorder case registry.
Journal of affective disorders 1999;52(1-3):93-9.
1999: Michael E Thase
Redefining antidepressant efficacy toward long-term recovery.
The Journal of clinical psychiatry 1999;60 Suppl 6():15-9.
1999: Jack R Cornelius; Ihsan Salloum; Roger F Haskett; JG Ehler; PJ Jarrett; Michael E Thase; James M Perel
Fluoxetine versus placebo for the marijuana use of depressed alcoholics.
Addictive behaviors 1999;24(1):111-4.
1999: Michael E Thase
How should efficacy be evaluated in randomized clinical trials of treatments for depression?
The Journal of clinical psychiatry 1999;60 Suppl 4():23-31; discussion 32.
1999: Ellen Frank; Michael E Thase
Natural history and preventative treatment of recurrent mood disorders.
Annual review of medicine 1999;50():453-68.
1998: Robert M A Hirschfeld; James M Russell; Pedro Delgado; Jan Fawcett; R A Friedman; Wilma M Harrison; Lorrin M Koran; Ivan W Miller; Michael E Thase; Robert H Howland; M A Connolly; RJ Miceli
Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.
The Journal of clinical psychiatry 1998;59(12):669-75.
1998: Martin B Keller; James H Kocsis; Michael E Thase; Alan J Gelenberg; A John Rush; Lorrin M Koran; Alan F Schatzberg; J Russell; Robert M A Hirschfeld; D Klein; James P McCullough; JA Fawcett; Susan G Kornstein; Lisa M LaVange; Wilma Harrison
Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial.
JAMA : the journal of the American Medical Association 1998;280(19):1665-72.
1998: Ivan W Miller; Gabor I Keitner; Alan F Schatzberg; Daniel N Klein; Michael E Thase; A John Rush; John Markowitz; D S Schlager; Susan G Kornstein; Sonia M Davis; Wilma M Harrison; Martin B Keller
The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.
The Journal of clinical psychiatry 1998;59(11):608-19.
1998: Martin B Keller; Alan J Gelenberg; Robert M A Hirschfeld; A John Rush; Michael E Thase; James H Kocsis; John Markowitz; JA Fawcett; Lorrin M Koran; Daniel N Klein; James M Russell; Susan G Kornstein; James P McCullough; Sonia M Davis; Wilma M Harrison
The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.
The Journal of clinical psychiatry 1998;59(11):598-607.
1998: A John Rush; Lorrin M Koran; Martin B Keller; John Markowitz; Wilma M Harrison; RJ Miceli; JA Fawcett; Alan J Gelenberg; Robert M A Hirschfeld; Daniel N Klein; James H Kocsis; James P McCullough; Alan F Schatzberg; Michael E Thase
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies.
The Journal of clinical psychiatry 1998;59(11):589-97.
1998: Michael E Thase
Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients.
The Journal of clinical psychiatry 1998;59(10):502-8.
1998: Paul Crits-Christoph; Lynne Siqueland; Jesse Chittams; Jacques P Barber; Aaron T Beck; Arlene Frank; Bruce Liese; Lester Luborsky; D Mark; Delinda Mercer; LS Onken; Lisa Najavits; Michael E Thase; George E Woody
Training in cognitive, supportive-expressive, and drug counseling therapies for cocaine dependence.
Journal of consulting and clinical psychology 1998;66(3):484-92.
1998: John A Sweeney; M H Strojwas; J John Mann; Michael E Thase
Prefrontal and cerebellar abnormalities in major depression: evidence from oculomotor studies.
Biological psychiatry 1998;43(8):584-94.
1998: Michael E Thase; Amy L Fasiczka; Susan R Berman; AD Simons; Charles F Reynolds
Electroencephalographic sleep profiles before and after cognitive behavior therapy of depression.
Archives of general psychiatry 1998;55(2):138-44.
1998: Lisa Najavits; David Gastfriend; Jacques P Barber; S Reif; Larry R Muenz; Jack Blaine; Arlene Frank; Paul Crits-Christoph; Michael E Thase; Roger D Weiss
Cocaine dependence with and without PTSD among subjects in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study.
The American journal of psychiatry 1998;155(2):214-9.
1998: Michael E Thase; Robert H Howland; Edward S Friedman
Treating antidepressant nonresponders with augmentation strategies: an overview.
The Journal of clinical psychiatry 1998;59 Suppl 5():5-12; discussion 13-5.
1998: Jack R Cornelius; Ihsan Salloum; Michael E Thase; Roger F Haskett; Dennis C Daley; A Jones-Barlock; C Upsher; James M Perel
Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
Psychopharmacology bulletin 1998;34(1):117-21.
1998: Ihsan Salloum; Jack R Cornelius; Michael E Thase; Dennis C Daley; Levent Kirisci; C Spotts
Naltrexone utility in depressed alcoholics.
Psychopharmacology bulletin 1998;34(1):111-5.
1998: Michael E Thase
Depression, sleep, and antidepressants.
The Journal of clinical psychiatry 1998;59 Suppl 4():55-65.
1998: Lisa Najavits; Roger D Weiss; S Reif; David Gastfriend; Lynne Siqueland; Jacques P Barber; Stephen F Butler; Michael E Thase; Jack Blaine
The Addiction Severity Index as a screen for trauma and posttraumatic stress disorder.
Journal of studies on alcohol 1998;59(1):56-62.
1998: Jack R Cornelius; Michael E Thase; Ihsan Salloum; Marie D Cornelius; A Black; J John Mann
Cocaine use associated with increased suicidal behavior in depressed alcoholics.
Addictive behaviors 1998;23(1):119-21.
1997: Michael E Thase; J B Greenhouse; Ellen Frank; Charles F Reynolds; P A Pilkonis; Karen E Hurley; Victoria J Grochocinski; David J Kupfer
Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations.
Archives of general psychiatry 1997;54(11):1009-15.
1997: Michael E Thase
Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group.
The Journal of clinical psychiatry 1997;58(9):393-8.
1997: Paul Crits-Christoph; Lynne Siqueland; Jack Blaine; Arlene Frank; Lester Luborsky; LS Onken; Larry R Muenz; Michael E Thase; Roger D Weiss; David Gastfriend; George E Woody; Jacques P Barber; Stephen F Butler; Dennis C Daley; S Bishop; Lisa Najavits; Judy Lis; Delinda Mercer; Margaret L Griffin; Karla Moras; Aaron T Beck
The National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Rationale and methods.
Archives of general psychiatry 1997;54(8):721-6.
1997: Jack R Cornelius; Ihsan Salloum; JG Ehler; PJ Jarrett; Marie D Cornelius; James M Perel; Michael E Thase; A Black
Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial.
Archives of general psychiatry 1997;54(8):700-5.
1997: Michael E Thase; David J Kupfer; A J Fasiczka; Daniel J Buysse; AD Simons; Ellen Frank
Identifying an abnormal electroencephalographic sleep profile to characterize major depressive disorder.
Biological psychiatry 1997;41(9):964-73.
1997: ALAN MALLINGER; Ellen Frank; Michael E Thase; CS Dippold; David J Kupfer
Low rate of membrane lithium transport during treatment correlates with outcome of maintenance pharmacotherapy in bipolar disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;16(5):325-32.
1997: Lawrence P Riso; Michael E Thase; Robert H Howland; Edward S Friedman; AD Simons; XM Tu
A prospective test of criteria for response, remission, relapse, recovery, and recurrence in depressed patients treated with cognitive behavior therapy.
Journal of affective disorders 1997;43(2):131-42.
1997: Benoit H Mulsant; Roger F Haskett; Joan Prudic; Michael E Thase; Kevin M Malone; J John Mann; H M Pettinati; Harold A Sackeim
Low use of neuroleptic drugs in the treatment of psychotic major depression.
The American journal of psychiatry 1997;154(4):559-61.
1997: Michael E Thase; Daniel J Buysse; Ellen Frank; C R Cherry; Cleon Cornes; ALAN MALLINGER; David J Kupfer
Which depressed patients will respond to interpersonal psychotherapy? The role of abnormal EEG sleep profiles.
The American journal of psychiatry 1997;154(4):502-9.
1997: Richard C Shelton; J Davidson; Kimberly A Yonkers; L Koran; Michael E Thase; Teri Pearlstein; Uriel Halbreich
The undertreatment of dysthymia.
The Journal of clinical psychiatry 1997;58(2):59-65.
1997: Michael E Thase; A John Rush
When at first you don't succeed: sequential strategies for antidepressant nonresponders.
The Journal of clinical psychiatry 1997;58 Suppl 13():23-9.
1997: A John Rush; Michael E Thase
Strategies and tactics in the treatment of chronic depression.
The Journal of clinical psychiatry 1997;58 Suppl 13():14-22.
1997: Michael E Thase
Psychotherapy of refractory depressions.
Depression and anxiety 1997;5(4):190-201.
1997: Michael E Thase
Integrating psychotherapy and pharmacotherapy for treatment of major depressive disorder. Current status and future considerations.
The Journal of psychotherapy practice and research 1997;6(4):300-6.
1997: Stefanie Hlastala; Ellen Frank; ALAN MALLINGER; Michael E Thase; AM Ritenour; David J Kupfer
Bipolar depression: an underestimated treatment challenge.
Depression and anxiety 1997;5(2):73-83.
1997: Jack R Cornelius; Ihsan Salloum; JG Ehler; PJ Jarrett; Marie D Cornelius; A Black; James M Perel; Michael E Thase
Double-blind fluoxetine in depressed alcoholic smokers.
Psychopharmacology bulletin 1997;33(1):165-70.
1997: Lisa Najavits; David Gastfriend; E Y Nakayama; Jacques P Barber; Jack Blaine; Arlene Frank; Larry R Muenz; Michael E Thase
A measure of readiness for substance abuse treatment. Psychometric properties of the RAATE-R interview.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 1997;6(1):74-82.
1997: Michael E Thase; S L Blomgren; M A Birkett; JT Apter; R G Tepner
Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline.
The Journal of clinical psychiatry 1997;58(1):16-21.
1996: Jack R Cornelius; Ihsan Salloum; Nancy L Day; Michael E Thase; J John Mann
Patterns of suicidality and alcohol use in alcoholics with major depression.
Alcoholism, clinical and experimental research 1996;20(8):1451-5.
1996: Charles F Reynolds; Ellen Frank; David J Kupfer; Michael E Thase; James M Perel; Sati Mazumdar; Patricia R Houck
Treatment outcome in recurrent major depression: a post hoc comparison of elderly ("young old") and midlife patients.
The American journal of psychiatry 1996;153(10):1288-92.
1996: Michael E Thase; M Fava; U Halbreich; J H Kocsis; L Koran; J Davidson; J Rosenbaum; W Harrison
A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
Archives of general psychiatry 1996;53(9):777-84.
1996: Michael E Thase; David J Kupfer
Recent developments in the pharmacotherapy of mood disorders.
Journal of consulting and clinical psychology 1996;64(4):646-59.
1996: Ihsan Salloum; Dennis C Daley; Jack R Cornelius; Levent Kirisci; Michael E Thase
Disproportionate lethality in psychiatric patients with concurrent alcohol and cocaine abuse.
The American journal of psychiatry 1996;153(7):953-5.
1996: Michael E Thase; S Dubé; K Bowler; R H Howland; J E Myers; E Friedman; D B Jarrett
Hypothalamic-pituitary-adrenocortical activity and response to cognitive behavior therapy in unmedicated, hospitalized depressed patients.
The American journal of psychiatry 1996;153(7):886-91.
1996: Michael E Thase
The role of Axis II comorbidity in the management of patients with treatment-resistant depression.
The Psychiatric clinics of North America 1996;19(2):287-309.
1996: Michael E Thase
Antidepressant options: venlafaxine in perspective.
Journal of clinical psychopharmacology 1996;16(3 Suppl 2):10S-18S; discussion 18S-20S.
1996: Jack R Cornelius; Horacio Fabrega; Marie D Cornelius; J Mezzich; P J Maher; Ihsan Salloum; Michael E Thase; RF Ulrich
Racial effects on the clinical presentation of alcoholics at a psychiatric hospital.
Comprehensive psychiatry 1996;37(2):102-8.
1996: Michael E Thase; AD Simons; Charles F Reynolds
Abnormal electroencephalographic sleep profiles in major depression: association with response to cognitive behavior therapy.
Archives of general psychiatry 1996;53(2):99-108.
1996: Michael E Thase
Response.
The Journal of psychotherapy practice and research 1996;5(4):283-5.
1995: Jack R Cornelius; P J Jarrett; Michael E Thase; Horacio Fabrega; Gretchen L Haas; A Jones-Barlock; J E Mezzich; RF Ulrich
Gender effects on the clinical presentation of alcoholics at a psychiatric hospital.
Comprehensive psychiatry 1995;36(6):435-40.
1995: Michael E Thase; David J Kupfer; Daniel J Buysse; Ellen Frank; AD Simons; A B McEachran; K F Rashid; Victoria J Grochocinski
Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression: I. Comparison during acute depressive states.
Biological psychiatry 1995;38(8):506-15.
1995: Michael E Thase; M H Trivedi; A John Rush
MAOIs in the contemporary treatment of depression.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1995;12(3):185-219.
1995: Jack R Cornelius; Ihsan Salloum; J Mezzich; Marie D Cornelius; Horacio Fabrega; J G Ehler; RF Ulrich; Michael E Thase; J John Mann
Disproportionate suicidality in patients with comorbid major depression and alcoholism.
The American journal of psychiatry 1995;152(3):358-64.
1995: Eric A Nofzinger; Charles F Reynolds; Michael E Thase; Ellen Frank; J Richard Jennings; A L Fasiczka; L R Sullivan; David J Kupfer
REM sleep enhancement by bupropion in depressed men.
The American journal of psychiatry 1995;152(2):274-6.
1995: Ihsan Salloum; Jack R Cornelius; Dennis C Daley; Michael E Thase
The utility of diazepam loading in the treatment of alcohol withdrawal among psychiatric inpatients.
Psychopharmacology bulletin 1995;31(2):305-10.
1994: Michael E Thase; Charles F Reynolds; Ellen Frank; J Richard Jennings; Eric A Nofzinger; A L Fasiczka; G Garamoni; David J Kupfer
Polysomnographic studies of unmedicated depressed men before and after cognitive behavioral therapy.
The American journal of psychiatry 1994;151(11):1615-22.
1994: Jack R Cornelius; Horacio Fabrega; J Mezzich; RF Ulrich; Michael E Thase
Characterizing organic mood syndrome, manic type.
Comprehensive psychiatry 1994;35(5):354-60.
1994: S L Johnson; S Monroe; A Simons; Michael E Thase
Clinical characteristics associated with interpersonal depression: symptoms, course and treatment response.
Journal of affective disorders 1994;31(2):97-109.
1994: Michael E Thase; Charles F Reynolds; Ellen Frank; AD Simons; J McGeary; A L Fasiczka; G G Garamoni; J Richard Jennings; David J Kupfer
Do depressed men and women respond similarly to cognitive behavior therapy?
The American journal of psychiatry 1994;151(4):500-5.
1994: Eric A Nofzinger; R M Schwartz; Charles F Reynolds; Michael E Thase; J Richard Jennings; Ellen Frank; A L Fasiczka; G L Garamoni; David J Kupfer
Affect intensity and phasic REM sleep in depressed men before and after treatment with cognitive-behavioral therapy.
Journal of consulting and clinical psychology 1994;62(1):83-91.
1993: J E Myers; Daniel J Buysse; Michael E Thase; James M Perel; Jean M Miewald; T B Cooper; David J Kupfer; J John Mann
The effects of fenfluramine on sleep and prolactin in depressed inpatients: a comparison of potential indices of brain serotonergic responsivity.
Biological psychiatry 1993;34(11):753-8.
1993: Eric A Nofzinger; R M Schwartz; Charles F Reynolds; Michael E Thase; J Richard Jennings; Ellen Frank; A L Fasiczka; G L Garamoni; David J Kupfer
Correlation of nocturnal penile tumescence and daytime affect intensity in depressed men.
Psychiatry research 1993;49(2):139-50.
1993: Robert H Howland; Michael E Thase
A comprehensive review of cyclothymic disorder.
The Journal of nervous and mental disease 1993;181(8):485-93.
1993: Ellen Frank; David J Kupfer; James M Perel; Cleon Cornes; ALAN MALLINGER; Michael E Thase; A B McEachran; Victoria J Grochocinski
Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression.
Journal of affective disorders 1993;27(3):139-45.
1993: Eric A Nofzinger; A L Fasiczka; Michael E Thase; Charles F Reynolds; Ellen Frank; J Richard Jennings; G L Garamoni; J V Matzzie; David J Kupfer
Are buckling force measurements reliable in nocturnal penile tumescence studies?
Sleep 1993;16(2):156-62.
1993: Eric A Nofzinger; Michael E Thase; Charles F Reynolds; Ellen Frank; J Richard Jennings; G L Garamoni; A L Fasiczka; David J Kupfer
Sexual function in depressed men. Assessment by self-report, behavioral, and nocturnal penile tumescence measures before and after treatment with cognitive behavior therapy.
Archives of general psychiatry 1993;50(1):24-30.
1993: Michael E Thase; AD Simons; Charles F Reynolds
Psychobiological correlates of poor response to cognitive behavior therapy: potential indications for antidepressant pharmacotherapy.
Psychopharmacology bulletin 1993;29(2):293-301.
1993: Jack R Cornelius; Ihsan Salloum; Marie D Cornelius; James M Perel; Michael E Thase; J G Ehler; J John Mann
Fluoxetine trial in suicidal depressed alcoholics.
Psychopharmacology bulletin 1993;29(2):195-9.
1993: Kevin M Malone; Michael E Thase; Tammy A Mieczkowski; J E Myers; Stacy Stull; T B Cooper; J John Mann
Fenfluramine challenge test as a predictor of outcome in major depression.
Psychopharmacology bulletin 1993;29(2):155-61.
1992: David J Kupfer; Ellen Frank; James M Perel; Cleon Cornes; ALAN MALLINGER; Michael E Thase; A B McEachran; Victoria J Grochocinski
Five-year outcome for maintenance therapies in recurrent depression.
Archives of general psychiatry 1992;49(10):769-73.
1992: Michael E Thase
Long-term treatments of recurrent depressive disorders.
The Journal of clinical psychiatry 1992;53 Suppl():32-44.
1992: Michael E Thase; AD Simons; J McGeary; J F Cahalane; C Hughes; T Harden; E Friedman
Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment.
The American journal of psychiatry 1992;149(8):1046-52.
1992: Michael E Thase; Charles F Reynolds; J Richard Jennings; Ellen Frank; G L Garamoni; Eric A Nofzinger; A L Fascizka; David J Kupfer
Diminished nocturnal penile tumescence in depression: a replication study.
Biological psychiatry 1992;31(11):1136-42.
1992: G L Garamoni; Charles F Reynolds; Michael E Thase; Ellen Frank; A L Fasiczka
Shifts in affective balance during cognitive therapy of major depression.
Journal of consulting and clinical psychology 1992;60(2):260-6.
1992: S Stuart; AD Simons; Michael E Thase; Paul A Pilkonis
Are personality assessments valid in acute major depression?
Journal of affective disorders 1992;24(4):281-9.
1992: Michael E Thase; ALAN MALLINGER; D McKnight; J M Himmelhoch
Treatment of imipramine-resistant recurrent depression, IV: A double-blind crossover study of tranylcypromine for anergic bipolar depression.
The American journal of psychiatry 1992;149(2):195-8.
1992: Michael E Thase; Charles F Reynolds; Ellen Frank; J Richard Jennings; G L Garamoni; A L Yeager; David J Kupfer
Early return to REM sleep after nocturnal awakening in depression.
Biological psychiatry 1992;31(2):171-6.
1992: Michael E Thase; AD Simons
The applied use of psychotherapy in the study of the psychobiology of depression.
The Journal of psychotherapy practice and research 1992;1(1):72-80.
1992: Michael E Thase; Ellen Frank; ALAN MALLINGER; T Hamer; David J Kupfer
Treatment of imipramine-resistant recurrent depression, III: Efficacy of monoamine oxidase inhibitors.
The Journal of clinical psychiatry 1992;53(1):5-11.
1992: Eric A Nofzinger; Charles F Reynolds; J Richard Jennings; Michael E Thase; Ellen Frank; A Yeager; David J Kupfer
Results of nocturnal penile tumescence studies are abnormal in sexually functional diabetic men.
Archives of internal medicine 1992;152(1):114-8.
1992: Michael E Thase; AD Simons
Cognitive behavior therapy and relapse of nonbipolar depression: parallels with pharmacotherapy.
Psychopharmacology bulletin 1992;28(2):117-22.
1992: E Frank; J M Perel; ALAN MALLINGER; Michael E Thase; D J Kupfer
Relationship of pharmacologic compliance to long-term prophylaxis in recurrent depression.
Psychopharmacology bulletin 1992;28(3):231-5.
1991: G L Garamoni; Charles F Reynolds; Michael E Thase; Ellen Frank; S R Berman; A L Fasiczka
The balance of positive and negative affects in major depression: a further test of the States of Mind model.
Psychiatry research 1991;39(2):99-108.
1991: Eric A Nofzinger; Michael E Thase; Charles F Reynolds; J M Himmelhoch; ALAN MALLINGER; Patricia Houck; David J Kupfer
Hypersomnia in bipolar depression: a comparison with narcolepsy using the multiple sleep latency test.
The American journal of psychiatry 1991;148(9):1177-81.
1991: R H Howland; Michael E Thase
Biological studies of dysthymia.
Biological psychiatry 1991;30(3):283-304.
1991: J M Himmelhoch; Michael E Thase; ALAN MALLINGER; Patricia Houck
Tranylcypromine versus imipramine in anergic bipolar depression.
The American journal of psychiatry 1991;148(7):910-6.
1991: Michael E Thase; AD Simons; J Cahalane; J McGeary; T Harden
Severity of depression and response to cognitive behavior therapy.
The American journal of psychiatry 1991;148(6):784-9.
1991: Michael E Thase; L Carpenter; D J Kupfer; Ellen Frank
Clinical significance of reversed vegetative subtypes of recurrent major depression.
Psychopharmacology bulletin 1991;27(1):17-22.
1990: Ellen Frank; David J Kupfer; James M Perel; Cleon Cornes; D B Jarrett; ALAN MALLINGER; Michael E Thase; A B McEachran; Victoria J Grochocinski
Three-year outcomes for maintenance therapies in recurrent depression.
Archives of general psychiatry 1990;47(12):1093-9.
1990: Charles F Reynolds; David J Kupfer; Michael E Thase; Ellen Frank; D B Jarrett; P A Coble; Carolyn C Hoch; Daniel J Buysse; AD Simons; Patricia R Houck
Sleep, gender, and depression: an analysis of gender effects on the electroencephalographic sleep of 302 depressed outpatients.
Biological psychiatry 1990;28(8):673-84.
1990: ALAN MALLINGER; J M Himmelhoch; Michael E Thase; DJ Edwards; S Knopf
Plasma tranylcypromine: relationship to pharmacokinetic variables and clinical antidepressant actions.
Journal of clinical psychopharmacology 1990;10(3):176-83.
1990: ALAN MALLINGER; J M Himmelhoch; Michael E Thase; CS Dippold; S Knopf
Reduced cell membrane affinity for lithium ion during maintenance treatment of bipolar affective disorder.
Biological psychiatry 1990;27(7):795-8.
1989: Michael E Thase; David J Kupfer; Ellen Frank; D B Jarrett
Treatment of imipramine-resistant recurrent depression: II. An open clinical trial of lithium augmentation.
The Journal of clinical psychiatry 1989;50(11):413-7.
1989: Michael E Thase; David J Kupfer; D B Jarrett
Treatment of imipramine-resistant recurrent depression: I. An open clinical trial of adjunctive L-triiodothyronine.
The Journal of clinical psychiatry 1989;50(10):385-8.
1989: Charles F Reynolds; Michael E Thase; J Richard Jennings; J R Howell; Ellen Frank; S R Berman; Patricia R Houck; David J Kupfer
Nocturnal penile tumescence in healthy 20- to 59-year-olds: a revisit.
Sleep 1989;12(4):368-73.
1989: Michael E Thase; J M Himmelhoch; ALAN MALLINGER; D B Jarrett; David J Kupfer
Sleep EEG and DST findings in anergic bipolar depression.
The American journal of psychiatry 1989;146(3):329-33.
1988: Michael E Thase; Charles F Reynolds; J Richard Jennings; S R Berman; Patricia R Houck; J R Howell; Ellen Frank; David J Kupfer
Diagnostic performance of nocturnal penile tumescence studies in healthy, dysfunctional (impotent), and depressed men.
Psychiatry research 1988;26(1):79-87.
1988: Charles F Reynolds; Ellen Frank; Michael E Thase; Patricia R Houck; J Richard Jennings; J R Howell; S O Lilienfeld; David J Kupfer
Assessment of sexual function in depressed, impotent, and healthy men: factor analysis of a Brief Sexual Function Questionnaire for men.
Psychiatry research 1988;24(3):231-50.
1988: Michael E Thase; Charles F Reynolds; J Richard Jennings; Ellen Frank; J R Howell; Patricia R Houck; S Berman; David J Kupfer
Nocturnal penile tumescence is diminished in depressed men.
Biological psychiatry 1988;24(1):33-46.
1987: Michael E Thase; Charles F Reynolds; J Richard Jennings; Ellen Frank; J Howell; Patricia R Houck; David J Kupfer
Do nocturnal penile tumescence recordings alter electroencephalographic sleep?
Sleep 1987;10(5):486-90.
1987: P I Campbell; Charles F Reynolds; J Richard Jennings; Michael E Thase; Ellen Frank; J Howell; David J Kupfer
Reliability of NPT scoring and visual estimates of erectile fullness.
Sleep 1987;10(5):480-5.
1987: ALAN MALLINGER; I Hanin; J M Himmelhoch; Michael E Thase; S Knopf
Stimulation of cell membrane sodium transport activity by lithium: possible relationship to therapeutic action.
Psychiatry research 1987;22(1):49-59.
1987: J R Howell; Charles F Reynolds; Michael E Thase; Ellen Frank; J Richard Jennings; Patricia R Houck; S Berman; E Jacobs; David J Kupfer
Assessment of sexual function, interest and activity in depressed men.
Journal of affective disorders 1987;13(1):61-6.